resourceId,softwareName,softwareType,softwareVersion,programmingLanguage,sourceRepository,documentation,licenseType,containerized,maintainer,_resourceName,_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType
RESb5afb97f,Fiber Photometry Trace Processing,Analysis Software,,MATLAB,https://github.com/GradinaruLab/dLight1/blob/master/FP_Session_Processing2.m,,,,,Fiber Photometry Trace Processing,PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,Fiber Photometry Trace Processing Gradinaru Lab FP_Session_Processing_2.m https://github.com/GradinaruLab/dLight1/blob/master/FP_Session_Processing2.m,0.9,Accept,Experimental Usage
RES63d689ad,Novoalign tool v3.02.06,Analysis Software,v3.02.06,,,,,,,Novoalign tool v3.02.06,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Sequence reads were mapped to the human reference genome (GRCh37/hg19) using Novoalign tool v3.02.06,0.95,Accept,Experimental Usage
RES7dbfc5c2,PICARD tools v2.4.1,Analysis Software,v2.4.1,,,,,,,PICARD tools v2.4.1,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,followed by marking and removing PCR duplicates by PICARD tools v2.4.1,0.95,Accept,Experimental Usage
RESe10f4cc0,Genome Analysis Toolkit (GATK) v3.6-0,Analysis Software,v3.6-0,,,,,,,Genome Analysis Toolkit (GATK) v3.6-0,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Local realignment around insertions/deletions was achieved by Genome Analysis Toolkit (GATK) v3.6-0,0.95,Accept,Experimental Usage
RES50c0898a,Mutect v1.1.4,Analysis Software,v1.1.4,,,,,,,Mutect v1.1.4,PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Somatic single-nucleotide variants were identified using Mutect v1.1.4,0.95,Accept,Experimental Usage
RES38b1e8e5,SciClone,Analysis Software,,,,,,,,SciClone,PMID:32642734 | PMID:32369930,10.1093/noajnl/vdz026 | 10.3390/genes11050499,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1. | Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Clonality was addressed using SciClone | SciClone and ClonEvol were utilized to attempt to perform a phylogeny inference,0.9,Accept,Experimental Usage
RES9faca75d,LMSz,Analysis Software,,,,,,,,LMSz,PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,...we implemented a recently described method called 'LMSz' to construct NF1-specific head circumference growth charts...,0.9,Accept,Experimental Usage
RES00ee3879,gamlssTools,Package/Library,,R,https://github.com/BGDlab/gamlssTools,,,,,gamlssTools,PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,...GAMLSS model visualization was performed using customized R functions (https://github.com/BGDlab/gamlssTools)...,0.9,Accept,Experimental Usage
RES0a319b7b,AXION Biosystems integrated studio (AxIS) version 2.5.1,Analysis Software,2.5.1,,,,,,,AXION Biosystems integrated studio (AxIS) version 2.5.1,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,All neurons were recorded for 3 min at a 4.5 standard deviation threshold level and 5000 Hz as a digital filter using AXION Biosystems integrated studio (AxIS) version 2.5.1 software,0.95,Accept,Experimental Usage
RES3d30cf7b,Offline sorter x64 version 4,Analysis Software,4,,,,,,,Offline sorter x64 version 4,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Representative traces of action potentials were extracted using the AXION Biosystems neural metric tool and Offline sorter x64 version 4 software,0.9,Accept,Experimental Usage
RES3cc070ad,"Partek Flow software, version 10.0",Analysis Software,10.0,,,,,,,"Partek Flow software, version 10.0",PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"The analysis for this paper was generated using Partek Flow software, version 10.0 using publicly available datasets",0.95,Accept,Experimental Usage
RESd6351c9b,STAR version 2.7.8a,Analysis Software,2.7.8a,,,,,,,STAR version 2.7.8a,PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,RNA-seq reads were aligned to the Ensembl release 100 top-level assembly with STAR version 2.7.8a,0.95,Accept,Experimental Usage
RESa45c6985,Splice Site Prediction by Neural Network (SSPNN),Web Application,,,,,,,,Splice Site Prediction by Neural Network (SSPNN),PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,"The sequence environment of all donor- and acceptor sites was analysed using Splice Site Prediction by Neural Network (SSPNN, URL address:",0.9,Accept,Experimental Usage
RES1a4561b4,mfold computer program version 3.0,Analysis Software,3.0,,,,,,,mfold computer program version 3.0,PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,The mfold computer program version 3.0 was used to predict the RNA secondary structure and to calculate the folding free energy,0.95,Accept,Experimental Usage
RES80c1ffab,Agilent Seahorse XF-96,Analysis Software,,,,,,,,Agilent Seahorse XF-96,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,We measured cellular energetics using Agilent Seahorse XF-96 Glyco Stress Test and Mito Stress Test assays,0.9,Accept,Experimental Usage
RESc4802159,STAR v2.7.8a,Analysis Software,v2.7.8a,,,,,,,STAR v2.7.8a,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,GENCODE was used to map FASTQ files to GRCh38 (release 33 with STAR v2.7.8a basic two-pass mode),0.9,Accept,Experimental Usage
RES5402ec17,iDEP 9.1,Analysis Software,9.1,,,,,,,iDEP 9.1,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,principal component analysis was computed using iDEP 9.1,0.9,Accept,Experimental Usage
RES046589af,Trim Galore v0.6.0,Analysis Software,v0.6.0,,,,,,,Trim Galore v0.6.0,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Trim Galore v0.6.0 was used to trim sequencing adapters from demultiplexed FASTQ files,0.9,Accept,Experimental Usage
RESdbdd1f9b,LipidSearch v5.0,Analysis Software,v5.0,,,,,,,LipidSearch v5.0,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"Lipid identifications were assigned using LipidSearch (v5.0, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage
RESe820b002,Compound Discoverer v3.2,Analysis Software,v3.2,,,,,,,Compound Discoverer v3.2,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"Data was analyzed using Compound Discoverer (v 3.2, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage
RES531667ca,SynergyFinder R package,Package/Library,,R,,,,,,SynergyFinder R package,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Synergy was calculated using the SynergyFinder R package,0.9,Accept,Experimental Usage
RES0f795f65,CEAS R Package,Package/Library,,R,,,,,,CEAS R Package,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"ATP metrics were calculated following Mookerjee et al., 2017 and using the CEAS R Package",0.9,Accept,Experimental Usage
RESf380cc7b,FactoMineR R package,Package/Library,,R,,,,,,FactoMineR R package,PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,PCA analysis was performed using the FactoMineR R package,0.9,Accept,Experimental Usage
RES792edde3,FlowJo software,Analysis Software,X10.0.7,,,,,,,FlowJo software,PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,data were processed with FlowJo software (version X10.0.7),0.85,Accept,Experimental Usage
RES9e99cde6,Orbitrap Fusion Lumos mass spectrometer,Analysis Software,,,,,,,,Orbitrap Fusion Lumos mass spectrometer,PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"An Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific Inc., Waltham, MA, USA)",0.9,Accept,Experimental Usage
RES635e70f9,SEDFIT 16.1,Analysis Software,16.1,,,,,,,SEDFIT 16.1,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Time-corrected data were analyzed in SEDFIT 16.1 in terms of a continuous c(s) distribution of sedimenting species,0.9,Accept,Experimental Usage
RES7b511162,SEDPHAT 14.0,Analysis Software,14.0,,,,,,,SEDPHAT 14.0,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Data were analyzed globally in terms of a single noninteracting species in SEDPHAT 14.0 to obtain the molar mass,0.9,Accept,Experimental Usage
RESbaadc961,EMAN2 e2boxer,Analysis Software,,,,,,,,EMAN2 e2boxer,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Negatively-stained neurofibromin particles were autopicked using EMAN2 e2boxer using a box size of 326 pixels,0.9,Accept,Experimental Usage
RES317c1cc6,Sphire,Package/Library,,,,,,,,Sphire,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,Reference-free 2D classification was carried out using the Iterative Stable Alignment and Clustering (ISAC) procedure implemented in a Sphire package,0.9,Accept,Experimental Usage
RES81980efb,ATSAS,Package/Library,,,,,,,,ATSAS,PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,The reduced SAXS and SANS data were analyzed using the ATSAS tools PRIMUS and GNOM for Guinier and P(r) analysis,0.9,Accept,Experimental Usage
RES45fb0b54,STAR 2.4.2a,Analysis Software,2.4.2a,,,,,,,STAR 2.4.2a,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Mapping was performed using STAR 2.4.2a software with mouse genome (mm9),0.9,Accept,Experimental Usage
RESac71d7d2,GSEA software 4.0.1,Analysis Software,4.0.1,,,,,,,GSEA software 4.0.1,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Gene set enrichment analysis (GSEA) was performed with the entire gene list using GSEA software 4.0.1 desktop (Broad Institute),0.9,Accept,Experimental Usage
RES0a763b47,DAVID 6.8,Web Application,6.8,,,,,,,DAVID 6.8,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,KEGG and gene ontology (GO) enrichment analysis was performed using the Signature Database (MSigDB) and DAVID 6.8,0.9,Accept,Experimental Usage
RES3c179eb9,MaxQuant (v1.5.3.30),Analysis Software,v1.5.3.30,,,,,,,MaxQuant (v1.5.3.30),PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Five micrograms of each SCX fraction and a non-fractioned sample were used for proteome profiling and analysed by MaxQuant (v1.5.3.30),0.9,Accept,Experimental Usage
RES572e3d0c,AxioVision 4.6 software,Analysis Software,4.6,,,,,,,AxioVision 4.6 software,PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Imaging was performed using a Zeiss Stereo Discovery V12 and the AxioVision 4.6 software (Zeiss),0.85,Accept,Experimental Usage
RES02458b5f,BwaMem,Analysis Software,v0.7.12,,,,,,,BwaMem,PMID:33025139 | PMID:32369930 | PMID:28051113 | PMID:36598417,10.1007/s00401-020-02230-x | 10.3390/genes11050499 | 10.1038/srep39348 | 10.1158/2159-8290.CD-22-0786,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.",,WGS data were aligned against hg19 using BwaMem v0.7.12 | Genomic data were aligned against reference sequence hg38 via BWA-MEM with Base Quality Score Recalibration (BQSR) | fastq files were mapped against the GRCh37 human genome assembly...using BWA mem | Amplicon reads were aligned against the human reference genome hg19 with BWA MEM | Raw sequencing reads were mapped to the GRCh38 build of the human reference genome using BWA-MEM (46) version 0.7.17-r1188,0.95,Accept,Experimental Usage
RES3e66f1c9,manta,Analysis Software,,,,,,,,manta,PMID:32369930 | PMID:36598417,10.3390/genes11050499 | 10.1158/2159-8290.CD-22-0786,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Structural variants (SVs) and large indels were detected using manta | we called SVs in all matched normal samples using Manta (version 1.6.0; ref. 55),0.9,Accept,Experimental Usage
RESe578b573,Pindel,Analysis Software,,,,,,,,Pindel,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"SNVs and small indels were detected using VarScan2, Strelka2, MuTect2, and Pindel",0.9,Accept,Experimental Usage
REScb60852b,GenVisR,Analysis Software,,,,,,,,GenVisR,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Waterfall somatic variant plots were created with GenVisR by including somatic variants that occurred in each area,0.9,Accept,Experimental Usage
RES30309c4e,COSMIC,Database,,,,,,,,COSMIC,PMID:32369930 | PMID:35332608,10.3390/genes11050499 | 10.1002/humu.24370,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | Re-evaluation of missense variant classifications in NF2.,,"These variants were not reported as a somatic variant in COSMIC (Catalogue Of Somatic Mutations In Cancer) and ClinVar archive | COSMIC ( www.cancer.sanger.ac.uk ) (Tate et al., 2019 ) was used in the investigation of variants that were observed in somatic samples",0.9,Accept,Experimental Usage
RES301ce5af,ClinVar,Database,,,,,,,,ClinVar,PMID:32369930 | PMID:40887659,10.3390/genes11050499 | 10.1186/s40246-025-00803-z,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. | RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,These variants were not reported as a somatic variant in COSMIC (Catalogue Of Somatic Mutations In Cancer) and ClinVar archive | ClinVar data for NF1 variants were extracted from the ClinVar version 2024-07-03 available at: https://ftp.ncbi.nlm.nih.gov/pub/clinvar/,0.9,Accept,Experimental Usage
RES69b283e6,SIFT,Analysis Software,,,,,,,,SIFT,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"In order to predict clinical significance and predictions of the functional effects of these variants, each variant was reviewed on SIFT and Polyphen",0.9,Accept,Experimental Usage
RESb870d8e5,Polyphen,Analysis Software,,,,,,,,Polyphen,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,"In order to predict clinical significance and predictions of the functional effects of these variants, each variant was reviewed on SIFT and Polyphen",0.9,Accept,Experimental Usage
RES42f49b0d,ClonEvol,Analysis Software,,,,,,,,ClonEvol,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,SciClone and ClonEvol were utilized to attempt to perform a phylogeny inference,0.9,Accept,Experimental Usage
RES6c7e4ee0,Partek Flow,Analysis Software,,,,,,,,Partek Flow,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Pre/post quality control and full expectation-maximization (EM) quantification were run via Partek Flow,0.9,Accept,Experimental Usage
RES2a6c19fe,gplots,Package/Library,,R,,,,,,gplots,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,Heatmap visualizations were created using gplots R package,0.9,Accept,Experimental Usage
RES40962237,PantherDB,Database,,,,,,,,PantherDB,PMID:32369930,10.3390/genes11050499,Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST.,,PantherDB was utilized to discover GO terms and pathways that may be affected by these genes,0.9,Accept,Experimental Usage
RES17d594ae,CompuSyn software Version 1.0,Analysis Software,1.0,,,,,,,CompuSyn software Version 1.0,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"Drug–drug interactions were analyzed with CompuSyn software Version 1.0 (Informer Technologies, Los Angeles, CA, USA; software is available at https://www.compusyn.software.informer.com",0.95,Accept,Experimental Usage
RES540c4fd8,IBM SPSS Statistics software version 29.0.1.0,Analysis Software,29.0.1.0,,,,,,,IBM SPSS Statistics software version 29.0.1.0,PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"In vivo S462TY sciatic nerve tumor xenograft data were analyzed using IBM SPSS Statistics software version 29.0.1.0 (IBM, Armonk, NY, USA).",0.9,Accept,Experimental Usage
RES01a14402,SPIN (Signal Processing in MR Version SVN Revision 1895),Analysis Software,SVN Revision 1895,,http://mrc.wayne.edu,,,,,SPIN (Signal Processing in MR Version SVN Revision 1895),PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,Internally developed MR software SPIN (Signal Processing in MR (Version SVN Revision 1895); http://mrc.wayne.edu (accessed on 15 December 2023)) was used for tumor volume measurement.,0.95,Accept,Experimental Usage
RES84d78bee,VarDict,Analysis Software,,Java,,,,,,VarDict,PMID:28398289 | PMID:36598417,10.1038/sdata.2017.45 | 10.1158/2159-8290.CD-22-0786,A high-throughput molecular data resource for cutaneous neurofibromas. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Somatic mutations were called from BAM files exported by the Dragen alignment using the Java version of VarDict in paired mode | and VarDict (version 1.8.2; ref. 52) were used to detect germline SNVs and INDELs in the WGS data,0.9,Accept,Experimental Usage
RES9b7fc522,SvABA,Analysis Software,1.1.3,,,,,,,SvABA,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"LUMPY (version 0.2.13; ref. 56), SvABA (version 1.1.3; ref. 57), and Delly (version 0.8.3; refs. 57, 58)",0.85,Accept,Experimental Usage
RES3606b596,MuSE,Analysis Software,v1.0rc,,,,,,,MuSE,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"Somatic SNVs were detected using Mutect2 (GATK version 4.1.8.0), MuSE (version v1.0rc; ref. 60)",0.85,Accept,Experimental Usage
RESdc410f70,MSIprofiler,Analysis Software,,,https://github.com/parklab/MSIprofiler,,,,,MSIprofiler,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Mutations at microsatellite loci were detected using MSIprofiler (https://github.com/parklab/MSIprofiler),0.85,Accept,Experimental Usage
RES08ded37b,FACETS,Analysis Software,0.12.1,,,,,,,FACETS,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"For WGS data, the software packages FACETS (version 0.12.1) and ascatNGS (version 2.5.1) were used to detect somatic copy-number alterations",0.85,Accept,Experimental Usage
RESb7598769,ascatNGS,Analysis Software,2.5.1,,,,,,,ascatNGS,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"For WGS data, the software packages FACETS (version 0.12.1) and ascatNGS (version 2.5.1) were used to detect somatic copy-number alterations",0.85,Accept,Experimental Usage
RES0d197494,ShatterSeek,Analysis Software,0.7,,,,,,,ShatterSeek,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Chromothripsis events were detected using ShatterSeek (version 0.7) using recommended cutoff values (72),0.85,Accept,Experimental Usage
RES36986283,TopHat-fusion,Analysis Software,2.1.0,,,,,,,TopHat-fusion,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"TopHat-fusion (version 2.1.0; ref. 78), EricScript (version 0.5.5; ref. 79), and STAR-Fusion (version 1.10.1; ref. 80)",0.85,Accept,Experimental Usage
RESc1b6f920,EricScript,Analysis Software,0.5.5,,,,,,,EricScript,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,"TopHat-fusion (version 2.1.0; ref. 78), EricScript (version 0.5.5; ref. 79), and STAR-Fusion (version 1.10.1; ref. 80)",0.85,Accept,Experimental Usage
RES7efd3489,minfi,Package/Library,3.3,R,,,,,,minfi,PMID:33025139 | PMID:35945463 | PMID:36598417 | PMID:38216587,10.1007/s00401-020-02230-x | 10.1007/s00401-022-02478-5 | 10.1158/2159-8290.CD-22-0786 | 10.1038/s41467-023-40408-5,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.",,Raw IDAT data files were processed using the minfi Bioconductor package (version 3.3) | Methylation data were preprocessed using the combineArrays function within the minfi package (v.1.38.0) in R Bioconductor | Raw Methylation EPIC data were uniformly processed using the R package minfi (version 1.34.0; ref. 86) | Data preprocessing and normalization was performed using minfi version 1.30 in R version 3.6.0,0.95,Accept,Experimental Usage
RES6e1f1a43,survival,Package/Library,2.30,R,,,,,,survival,PMID:36598417,10.1158/2159-8290.CD-22-0786,Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA.,,Survival analysis was performed using the Cox proportional-hazards model as implemented in the R package survival (version 2.30; ref. 93),0.85,Accept,Experimental Usage
RES87debe63,DNA Engine Peltier Thermal cycler (PTC-200),Other,,,,,,,,DNA Engine Peltier Thermal cycler (PTC-200),PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"in a DNA Engine Peltier Thermal cycler (PTC-200; MJ Research, Watertown, MA) at 42°C for 1 minute",0.9,Accept,Experimental Usage
RESb811b6f5,"ABI Prism 7,000 Sequence Detection System",Analysis Software,,,,,,,,"ABI Prism 7,000 Sequence Detection System",PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"An ABI Prism 7,000 Sequence Detection System was used for all reactions with the following cycling parameters",0.95,Accept,Experimental Usage
RES4c1a7278,Simpleware ScanIP,Analysis Software,,,,,,,,Simpleware ScanIP,PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,"To create the tumor models for the ground truth dataset, an image processing software (Simpleware ScanIP, Synopsys) was used.",0.95,Accept,Experimental Usage
RES718e94f6,DPP V1.0,Analysis Software,V1.0,,,,,,,DPP V1.0,PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,The helper (DPP V1.0) was trained using proprietary AI- and ML-based algorithms and information.,0.9,Accept,Development
RESfb594f2b,Simpleware,Analysis Software,,,,,,,,Simpleware,PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,"To create the tumor models an image processing software (Simpleware, Synopsys, Mountain View, CA) was used.",0.95,Accept,Experimental Usage
RES2eca2ac3,Phoenix WinNonlin (Version 8.1),Analysis Software,8.1,,,,,,,Phoenix WinNonlin (Version 8.1),PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A noncompartmental analysis was performed to estimate area under the concentration-time curve from time 0 to 12 hours (AUC 0-12h) after a single dose of mirdametinib using Phoenix WinNonlin (Version 8.1; Certara, Princeton, NJ).",0.85,Accept,Experimental Usage
RES71365145,NONMEM (version 7.2),Analysis Software,7.2,,,,,,,NONMEM (version 7.2),PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.85,Accept,Experimental Usage
RES0130ea80,Perl speaks NONMEM version 3.6.2,Package/Library,3.6.2,Perl,,,,,,Perl speaks NONMEM version 3.6.2,PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.8,Accept,Experimental Usage
RESc2a32cc0,Pirana version 2.7.1,Analysis Software,2.7.1,,,,,,,Pirana version 2.7.1,PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.8,Accept,Experimental Usage
RES2681766d,SPSS version 28.0,Analysis Software,28.0,,,,,,,SPSS version 28.0,PMID:38499890 | PMID:38811427,10.1186/s41687-024-00714-y | 10.1186/s41687-024-00732-w,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands. | Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.",,The statistical analyses were conducted using SPSS version 28.0 | Statistical analyses were performed using SPSS version 28.0,0.85,Accept,Experimental Usage
RESd283cb2e,www.synapse.org/SynodosNF2,Database,,,www.synapse.org/SynodosNF2,,,,,www.synapse.org/SynodosNF2,PMID:29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,,This work has created an openly accessible resource (www.synapse.org/SynodosNF2) of fully characterized isogenic schwannoma and meningioma cell systems,0.9,Accept,Development
RES3331b3ed,WGCNA,Package/Library,,R,,,,,,WGCNA,PMID:38115252 | PMID:35741605 | PMID:28166733,10.1097/MD.0000000000036696 | 10.3390/brainsci12060720 | 10.1186/s12864-017-3519-7,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools. | Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"WGCNA, an R package, was used to conduct WGCNA | Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ] | We used the 'collapseRows()' function with the 'maxmean' method from the R package WGCNA",0.95,Accept,Experimental Usage
RES72a7570b,ConsensusClusterPlus,Package/Library,,R,,,,,,ConsensusClusterPlus,PMID:35741605 | PMID:33025139 | PMID:38216572,10.3390/brainsci12060720 | 10.1007/s00401-020-02230-x | 10.1038/s41467-024-44755-9,"Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas. | Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.",,"Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ], ggplot2 [ 28 ], enrichplot [ 29 ], and ConsensusClusterPlus [ 30 ] | Subgroups were identified using ConsensusClusterPlus Bioconductor package | To identify DNA methylation groups, ConsensusClusterPlus (Bioconductor v3.10) was used",0.9,Accept,Experimental Usage
RES41529dd7,Mechanism Interrogation PlatE (MIPE 4.0) library,Database,,,,,,,,Mechanism Interrogation PlatE (MIPE 4.0) library,PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,The drug screening data were contributed by Ferrer et al. using the Mechanism Interrogation PlatE (MIPE 4.0) library [ 6 ],0.9,Accept,Experimental Usage
RESb4a5ed5c,IDAPredict.2drug function package,Package/Library,,,,,,,,IDAPredict.2drug function package,PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,,IDAPredict.2drug function package was used to predict the drug combination between DrugCluster pairs [ 23 ],0.9,Accept,Experimental Usage
RES95522299,Barocycler NEP 2320,Other,,,,,,,,Barocycler NEP 2320,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...Pressure-based cell lysis was performed for 60 cycles of 50 s at 30 °C and 310 MPa using the Barocycler NEP 2320 instrument (Pressure BioSciences, Easton, MA, USA)...",0.9,Accept,Experimental Usage
RES7097dd8c,Easy-nLC 1200,Other,,,,,,,,Easy-nLC 1200,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...A nanoflow high-performance liquid chromatography system Easy-nLC 1200 coupled to the Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany)...",0.9,Accept,Experimental Usage
RESa93de1e2,Q Exactive HF mass spectrometer,Other,,,,,,,,Q Exactive HF mass spectrometer,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...Easy-nLC 1200 coupled to the Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a nano-electrospray ionization source...",0.9,Accept,Experimental Usage
RES4f0adae1,Thermo Xcalibur 4.1,Analysis Software,4.1,,,,,,,Thermo Xcalibur 4.1,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...The data were acquired automatically using Thermo Xcalibur 4.1 software (Thermo Fisher Scientific) and processed with the Spectronaut Pulsar software...,0.95,Accept,Experimental Usage
REScec052ec,Spectronaut Pulsar,Analysis Software,,,,,,,,Spectronaut Pulsar,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...processed with the Spectronaut Pulsar software (Biognosys, Schlieren, Switzerland). Pulsar is a search engine, integrated into Spectronaut for spectral library generation...",0.95,Accept,Experimental Usage
RES061af0c5,BenchMark Ultra system,Other,,,,,,,,BenchMark Ultra system,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...The Ki67 immunohistochemistry was performed using the BenchMark Ultra system (Roche)...,0.9,Accept,Experimental Usage
RES5cd84067,NanoZoomer S60 digital slide scanner,Other,,,,,,,,NanoZoomer S60 digital slide scanner,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...imaged using the NanoZoomer S60 digital slide scanner (Hamamatsu, Hamamatsu City, Japan)...",0.9,Accept,Experimental Usage
RESd7211543,Pannoramic Midi FL slide scanner,Other,,,,,,,,Pannoramic Midi FL slide scanner,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...and Pannoramic Midi FL slide scanner (3DHistech Ltd, Budapest, Hungary)...",0.9,Accept,Experimental Usage
RESf159deba,R software version 4.0.0,Analysis Software,4.0.0,R,,,,,,R software version 4.0.0,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...All analyses were performed using the R software for statistical computing, version 4.0.0, and package lmerTest, version 3.1-2...",0.95,Accept,Experimental Usage
RES0aa2ef89,lmerTest package version 3.1-2,Package/Library,3.1-2,R,,,,,,lmerTest package version 3.1-2,PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...using the R software for statistical computing, version 4.0.0, and package lmerTest, version 3.1-2...",0.95,Accept,Experimental Usage
RES03c4f218,AxioVision 4.1 software,Analysis Software,4.1,,,,,,,AxioVision 4.1 software,PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"Images were collected using a DMR HC microscope...and evaluated using AxioVision 4.1 software (Zeiss, Jena, Germany)",0.8,Accept,Experimental Usage
RESf75fb506,analySIS 5.0 software,Analysis Software,5.0,,,,,,,analySIS 5.0 software,PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,"Stained sections were analyzed using the BX51 microscope...and analySIS 5.0 software (Soft imaging system GmbH, Münster, Germany)",0.8,Accept,Experimental Usage
RESf9aadc33,Gel-Pro Analyzer 4.0,Analysis Software,4.0,,,,,,,Gel-Pro Analyzer 4.0,PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,"α-tubulin (Sigma, St. Louis, MO) was employed for normalization and densitometric analysis using Gel-Pro Analyzer 4.0 (Media Cybernetics, Bethesda, MD)",0.8,Accept,Experimental Usage
RES7b28da6e,"Alamut Visual Plus, version 1.5.1",Analysis Software,1.5.1,,,,,,,"Alamut Visual Plus, version 1.5.1",PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,"Splice site prediction software (Alamut Visual Plus, version 1.5.1; Sophia Genetics) was used to identify variants likely to affect pre-mRNA splicing",0.9,Accept,Experimental Usage
RES5fb0ffe8,R 2.7.0,Analysis Software,2.7.0,R,,,,,,R 2.7.0,PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,All analyses were performed on R 2.7.0.,0.85,Accept,Experimental Usage
RES749fe008,Axio Vision Rel. 4.8 software,Analysis Software,4.8,,,,,,,Axio Vision Rel. 4.8 software,PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,,Images were captured and analyzed using Axio Vision Rel. 4.8 software (Carl Zeiss MicroImaging),0.85,Accept,Experimental Usage
RES3900f64d,piXarray 100 DSR System,Analysis Software,1.0.6,,,,,,,piXarray 100 DSR System,PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"X-rays were taken using a piXarray 100 DSR System with Biopix Software (Version No: 1.0.6., Bioptics, Inc. Tucson, AZ)",0.8,Accept,Experimental Usage
RES773ba297,XCT Research SA + peripheral quantitative computed tomography (pQCT) scanner,Analysis Software,5.50,,,,,,,XCT Research SA + peripheral quantitative computed tomography (pQCT) scanner,PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"Whole axial bone was placed in the gantry of a XCT Research SA + peripheral quantitative computed tomography (pQCT) scanner (Stratec Medizintechnik GmbH, Pforzheim, Germany) with Software Version 5.50",0.8,Accept,Experimental Usage
RESe5742ad8,MtestwR software,Analysis Software,R 1.4.2,,,,,,,MtestwR software,PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"biomechanical testing was conducted utilizing Testresouse R systems with MtestwR software version: R 1.4.2 (TestResources Inc. Shakopee, MN)",0.8,Accept,Experimental Usage
REScde70bbd,FMRIB software library (FSL),Analysis Software,5.0,,,,,,,FMRIB software library (FSL),PMID:27081657 | PMID:28725547,10.1002/acn3.288 | 10.1016/j.nicl.2017.06.032,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I. | Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,"fMRI data analyses were performed using tools from the FMRIB software library ( www.fmrib.ox.ac.uk/fsl ), version 5.0 | FMRI data analyses were performed using the FMRIB software library (www.fmrib.ox.ac.uk/fsl), version 5.0",0.9,Accept,Experimental Usage
RES611629a4,XenoBase version 3.5,Analysis Software,3.5,,,,,,,XenoBase version 3.5,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Heat maps were generated using XenoBase® version 3.5 from Affymetrix array data using MAS 5.0 normalization,0.85,Accept,Experimental Usage
RESaa91395d,Affymetrix Expression Console MAS 5.0,Analysis Software,MAS 5.0,,,,,,,Affymetrix Expression Console MAS 5.0,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Microarray data was analyzed using Affymetrix expression console MAS 5.0 method,0.8,Accept,Experimental Usage
RES6f6fb2f4,StepOne Software v2.3,Analysis Software,v2.3,,,,,,,StepOne Software v2.3,PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,using StepOne Software v2.3 (Applied Biosystems) standard parameters,0.85,Accept,Experimental Usage
RES28b9bfd1,FSL version 5.0.7,Analysis Software,5.0.7,,,,,,,FSL version 5.0.7,PMID:32642741,10.1093/noajnl/vdaa037,Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.,,"Postprocessing DTI analysis was performed using a previously described method for automated probabilistic tractography of the optic radiations. Briefly, using FSL version 5.0.7 (FMRIB)",0.85,Accept,Experimental Usage
RES9aa69e07,"iPlan Net software (Brainlab, Feldkirchen, Germany)",Analysis Software,,,,,,,,"iPlan Net software (Brainlab, Feldkirchen, Germany)",PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,,"postcontrast thin-sliced (≤ 3 mm) T1-weighted magnetic resonance (MR) sequences were uploaded into the iPlan Net software (Brainlab, Feldkirchen, Germany), and volumes were measured manually or in combination with semiautomated segmentation",0.9,Accept,Experimental Usage
RESd773954e,"Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",Analysis Software,10.0,,,,,,,"Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,,"Statistical evaluation was performed using the Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",0.8,Accept,Experimental Usage
RES067151c9,CRISPOR,Web Application,,,,,,,,CRISPOR,PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Target sites within the genes of interest were selected using Massachusetts Institute of Technology's CRISPR design tool (now unavailable, previously: crispr.mit.edu, ), or later, CRISPOR",0.9,Accept,Experimental Usage
RESfb88b822,JMP Pro 15.0.0,Analysis Software,15.0.0,,,,,,,JMP Pro 15.0.0,PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Logistic regressions were performed in JMP (JMP Pro 15.0.0, SAS Institute Inc., Cary, NC)",0.8,Accept,Experimental Usage
RES26a60360,UN-SCAN-IT gel 6.1,Analysis Software,6.1,,,,,,,UN-SCAN-IT gel 6.1,PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",,band intensities were quantified using UN-SCAN-IT gel 6.1 software,0.85,Accept,Experimental Usage
RES8e1aac71,synergyfinder,Web Application,,,https://synergyfinder.fimm.fi/,,,,,synergyfinder,PMID:36730269 | PMID:33273014 | PMID:37410426 | PMID:40723243,10.1371/journal.pone.0277305 | 10.1074/jbc.RA120.014960 | 10.1158/1078-0432.CCR-23-0749 | 10.3390/cancers17142359,"Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas. | mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. | The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.",,We used the percent viability compared to untreated cells to calculate a synergy score for each of the analyzed combinations (https://synergyfinder.fimm.fi/) | Synergy scores were generated using the web-based SynergyFinder application (https://synergyfinder.fimm.fi/) | data analyzed using SynergyFinder (RRID: SCR-019318) | Drug synergy was evaluated using the Bliss independence model via the SynergyFinder online platform (https://synergyfinder.org/),0.95,Accept,Experimental Usage
RESff832e97,Image Studio Lite software,Analysis Software,,,,,,,,Image Studio Lite software,PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,Band intensity quantifications were done using Image Studio Lite software (RRID: SCR_013715),0.9,Accept,Experimental Usage
RESda500560,DINs (Deep Interactive Networks),Analysis Software,,Python,,,,,,DINs (Deep Interactive Networks),PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,we propose deep interactive networks (DINs) to address the above limitations. User interactions guide the model to recognize complicated tumors and quickly adapt to heterogeneous tumors.,0.95,Accept,Development
RES32f260c8,3DQI software,Analysis Software,,,,,,,,3DQI software,PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,Cai et al. perform volume measurements on the LRMRI data set using 3DQI software at Massachusetts General Hospital (MGH) and National Cancer Institute (NCI),0.9,Accept,Experimental Usage
RES5a46d343,MEDx software,Analysis Software,,,,,,,,MEDx software,PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,,Cai et al. perform volume measurements on the LRMRI data set using 3DQI software at Massachusetts General Hospital (MGH) and National Cancer Institute (NCI) and MEDx software at NCI,0.9,Accept,Experimental Usage
RESa598a1ba,InVivo 3.2.0 software,Analysis Software,3.2.0,,,,,,,InVivo 3.2.0 software,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Sections were viewed and imaged using an Olympus BX61 upright light microscope and Q imaging Retiga Exi camera with InVivo 3.2.0 software (Media Cybernetics),0.9,Accept,Experimental Usage
RESd4559b11,Image-Pro Plus software,Analysis Software,,,,,,,,Image-Pro Plus software,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Computerized quantitative morphometric analysis was performed using Image-Pro Plus software (Media Cybernetics),0.9,Accept,Experimental Usage
RESa7cf610d,GraphPad 5 Prism software,Analysis Software,5,,,,,,,GraphPad 5 Prism software,PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"Differences between Nf1+/- and Nf1+/+ groups were analyzed by 2-tailed Student's t tests and were graphed using GraphPad 5 Prism software (San Diego, Calif., USA)",0.85,Accept,Experimental Usage
RES92ec56f3,REDCap,Web Application,,,,,,,,REDCap,PMID:37269078,10.1177/17407745231178839,Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials.,,"Surveys were created in REDCap, a secure web-based data capture tool",0.9,Accept,Experimental Usage
RES26060c1f,"IBM SPSS for Windows, version 28",Analysis Software,version 28,,,,,,,"IBM SPSS for Windows, version 28",PMID:38475852,10.1186/s13023-024-03093-1,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,,"The data were analyzed using IBM SPSS for Windows, version 28",0.85,Accept,Experimental Usage
RES6a7d40be,GPower 3.1,Analysis Software,3.1,,,,,,,GPower 3.1,PMID:38475852,10.1186/s13023-024-03093-1,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,,A post-hoc power analysis was conducted using GPower 3.1 (n = 19),0.85,Accept,Experimental Usage
RES60fc1bb1,netMHCpan-4.0,Analysis Software,4.0,,,,,,,netMHCpan-4.0,PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,,Binding affinity of mutant and corresponding wild-type peptides to the patient's germline HLA alleles was predicted using netMHCpan-4.0,0.9,Accept,Experimental Usage
RES477ca922,CatWalk XT,Analysis Software,ver. 8,,,,,,,CatWalk XT,PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"We used the CatWalk XT (ver. 8, Noldus Information Technology, Wageningen, The Netherlands) system to study the functional recovery of the nerve",0.9,Accept,Experimental Usage
RES2c7845ec,Agilent ChemStation software (version C.01.07),Analysis Software,C.01.07,,,,,,,Agilent ChemStation software (version C.01.07),PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,An Agilent ChemStation software (version C.01.07) was used for data analysis,0.9,Accept,Experimental Usage
RESa0ea9b80,VivoQuant software version 4.0,Analysis Software,4.0,,,,,,,VivoQuant software version 4.0,PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"ROIs were manually drawn with VivoQuant software version 4.0 (Invicro, Needham, MA, USA)",0.95,Accept,Experimental Usage
RES20f7f8bb,MaxQuant version 1.3.05,Analysis Software,1.3.05,,,,,,,MaxQuant version 1.3.05,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Andromeda search engine integrated in MaxQuant version 1.3.05 programme was used to identify the proteins,0.95,Accept,Experimental Usage
RESccdc807c,DAVID software,Analysis Software,,,,,,,,DAVID software,PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"Functional enrichment analysis was performed using Benjamini-Hochberg multiple correction testing integrated in to the database for annotation, visualization and integrated discovery (DAVID) software",0.9,Accept,Experimental Usage
RESa7ae4788,log-rank Mantel-Cox test,Analysis Software,,,,,,,,log-rank Mantel-Cox test,PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,Kaplan-Meier plots were generated in GraphPad Prism and p-values were determined by log-rank Mantel-Cox test.,0.9,Accept,Experimental Usage
RESa453b7cc,spatial transcriptomics profiling,Analysis Software,,,,,,,,spatial transcriptomics profiling,PMID:40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,,"For patients in the institutional cohort whose samples underwent bulk RNA sequencing, whole exome sequencing and spatial transcriptomics profiling",0.9,Accept,Experimental Usage
RES91569a5d,TRAP (Tiled Regression Analysis Package),Analysis Software,,,,,,,,TRAP (Tiled Regression Analysis Package),PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"""Tiled Regression"" as implemented in TRAP (Tiled Regression Analysis Package) was used to identify the set of independent significant variants",0.9,Accept,Experimental Usage
RESedf6124e,GenomeStudio (v. 2010.2),Analysis Software,v. 2010.2,,,,,,,GenomeStudio (v. 2010.2),PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,SNP-array analysis was done according to the manufacturer's protocol using GenomeStudio (v. 2010.2) software,0.9,Accept,Experimental Usage
RESa37c1184,MaxQuant version 1.6.10.43,Analysis Software,1.6.10.43,,,,,,,MaxQuant version 1.6.10.43,PMID:36890585 | PMID:33442015,10.1186/s40478-023-01525-w | 10.1038/s41591-020-01193-6,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,MaxQuant version 1.6.10.43 [ 12 ] was used whilst enabling TMTpro 16-plex reporter ion quantitation | Raw files were processed for label-free quantification by MaxQuant (version 1.6.10.43) LFQ using the Uniprot/Swiss-Prot mouse database,0.95,Accept,Experimental Usage
RES07195dfa,Perseus (version 1.6.10.50),Analysis Software,1.6.10.50,,,,,,,Perseus (version 1.6.10.50),PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,LFQ intensities for kinases with at least two peptides were imported into Perseus (version 1.6.10.50),0.9,Accept,Experimental Usage
RESfe684353,FlowJo Software (version 9.9.6),Analysis Software,9.9.6,,,,,,,FlowJo Software (version 9.9.6),PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"Data were acquired uncompensated and exported as FCS 3.0 files for analysis using FlowJo Software (version 9.9.6,Tree Star Inc)",0.9,Accept,Experimental Usage
RESdf71b82a,HALO Image Analysis Software (version 2.3),Analysis Software,2.3,,,,,,,HALO Image Analysis Software (version 2.3),PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"representative image were generated using HALO Image Analysis Software (version 2.3, Indica Labs)",0.9,Accept,Experimental Usage
RESdb8dbe2a,XCELLigence Real Time Cell Analysis System,Analysis Software,,,,,,,,XCELLigence Real Time Cell Analysis System,PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"The microelectronic biosensor XCELLigence Real Time Cell Analysis System (RTCA, Roche Diagnostics GmbH",0.9,Accept,Experimental Usage
RES8f04a9dd,Primer 3.0,Analysis Software,3.0,,,,,,,Primer 3.0,PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,Primers were designed based on the mutation sites found using Primer 3.0,0.85,Accept,Experimental Usage
RES1854c01b,Feature Extraction 10.5,Analysis Software,10.5,,,,,,,Feature Extraction 10.5,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,Copy number estimates were extracted from the microarray image files using Feature Extraction 10.5 (Agilent),0.85,Accept,Experimental Usage
RES48a3bc4e,Agilent Genomic Workbench 6.5,Analysis Software,6.5,,,,,,,Agilent Genomic Workbench 6.5,PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,data were analyzed in Agilent Genomic Workbench 6.5 (Agilent),0.85,Accept,Experimental Usage
RES385b45f2,Drop-seq tools (version 1.12),Analysis Software,1.12,,,,,,,Drop-seq tools (version 1.12),PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"FASTQ sequencing reads were processed, aligned to the mouse genome (mm10), and converted to digital gene expression matrices using the Drop-seq tools (version 1.12)",0.9,Accept,Experimental Usage
RES4637dad3,Cellranger v5.0.1,Analysis Software,v5.0.1,,,,,,,Cellranger v5.0.1,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"For 10X Genomics datasets, we used Cellranger v5.0.1 to align reads to the hg19 human reference sequence",0.9,Accept,Experimental Usage
RESdd12d863,Seurat (version 3.1.0),Package/Library,3.1.0,R,,,,,,Seurat (version 3.1.0),PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"For each sample dataset, unsupervised clustering was performed using R package Seurat (version 3.1.0)",0.9,Accept,Experimental Usage
RES5dbcec52,scREF,Analysis Software,,,https://github.com/jumphone/scRef/archive/master.zip,,,,,scREF,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,scREF is a reference-based toolkit for single-cell analysis for mapping a query RNA-seq dataset onto a reference,0.85,Accept,Experimental Usage
RESae087f41,CIBERSORTx,Analysis Software,,,,,,,,CIBERSORTx,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,We used CIBERSORTx to perform deconvolution analysis of bulk tumor data against Lats1/2-mut advanced SN tumor cell types,0.9,Accept,Experimental Usage
RES8aa9eefe,inferCNV,Analysis Software,,,,,,,,inferCNV,PMID:36322658 | PMID:33591953,10.1126/sciadv.abo5442 | 10.1172/jci.insight.146351,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Malignant cells were identified by inferring large-scale chromosomal CNVs in each single cell based on a moving averaged expression profiles across chromosomal intervals by inferCNV | Copy number variations of each PDX were inferred from scRNA-seq using the R package inferCNV,0.9,Accept,Experimental Usage
RES1eda8a8e,VECTOR,Analysis Software,,,,,,,,VECTOR,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,Cell-state transition directions were inferred by VECTOR based on the observation that quantile polarization of a cell's principal component values,0.9,Accept,Experimental Usage
RES021b742f,Slingshot,Package/Library,,R,,,,,,Slingshot,PMID:36322658 | PMID:41591566,10.1126/sciadv.abo5442 | 10.1007/s00401-026-02979-7,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"Slingshot is a top performer for cellular trajectory from scRNA-seq data. We used Slingshot to model the pseudotime trajectory | To explore differentiation trajectories among tumor clusters, we applied Slingshot (Version: 2.12.0)",0.9,Accept,Experimental Usage
RES927c40f5,CytoTRACE version 0.3.3,Package/Library,0.3.3,R,,,,,,CytoTRACE version 0.3.3,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,we used the R package CytoTRACE version 0.3.3 to predict differentiation status of SC lineage cells from mouse and human scRNA-seq data,0.9,Accept,Experimental Usage
RES0072c440,ArchR,Package/Library,,R,,,,,,ArchR,PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"ArchR was used for all scATAC-seq analyses according to default parameters, including quality control and cell filtering",0.9,Accept,Experimental Usage
RESfc2801f1,CellChat,Package/Library,,R,,,,,,CellChat,PMID:36322658 | PMID:38907342,10.1126/sciadv.abo5442 | 10.1186/s40478-024-01821-z,"Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy. | snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"We used CellChat to infer the intercellular communication from scRNA-seq data for further data exploration, analysis, and visualization | After processing our snRNA-seq dataset in Seurat, downstream analysis in CellChat was conducted",0.9,Accept,Experimental Usage
RES77a9c53b,DGIdb (version 3.0.2),Database,3.0.2,,,,,,,DGIdb (version 3.0.2),PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"were used to query the Washington University DGIdb (version 3.0.2), with a focus on expert-curated collections of druggable genes",0.9,Accept,Experimental Usage
RESd8256a02,Trim Galore (version 0.6.10),Analysis Software,0.6.10,,,,,,,Trim Galore (version 0.6.10),PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The raw sequence reads were first trimmed using Trim Galore (version 0.6.10) to remove any primer adapter contamination,0.9,Accept,Experimental Usage
RES4c373806,Broad's Genome Analysis ToolKit (version 4.6.0),Analysis Software,4.6.0,,,,,,,Broad's Genome Analysis ToolKit (version 4.6.0),PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The trimmed sequence reads were further analyzed using Broad's Genome Analysis ToolKit (version 4.6.0) following their Best Practices Guidelines,0.9,Accept,Experimental Usage
RESf7503724,BWA (version 0.7.17-r1188),Analysis Software,0.7.17-r1188,,,,,,,BWA (version 0.7.17-r1188),PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle,0.9,Accept,Experimental Usage
RESdb33838a,Picard tools (version 3.2.0),Analysis Software,3.2.0,,,,,,,Picard tools (version 3.2.0),PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Duplicate reads were removed with Picard tools (version 3.2.0) and Base Quality Score Recalibration (BQSR) was then applied,0.9,Accept,Experimental Usage
RES5e518fa2,ReAdW v. 3.5.1,Analysis Software,3.5.1,,,,,,,ReAdW v. 3.5.1,PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The XCalibur RAW files were collected in profile mode, centroided and converted to MzXML using ReAdW v. 3.5.1",0.9,Accept,Experimental Usage
RES1861ffff,MzXML2Search (included in TPP v. 3.5),Analysis Software,3.5,,,,,,,MzXML2Search (included in TPP v. 3.5),PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The mgf files were then created using MzXML2Search (included in TPP v. 3.5) for all scans,0.9,Accept,Experimental Usage
RESb663bcef,"Scaffold (Protein Sciences, Portland Oregon)",Analysis Software,,,,,,,,"Scaffold (Protein Sciences, Portland Oregon)",PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The list of peptide IDs generated based on SEQUEST or MASCOT search results were filtered separately using Scaffold (Protein Sciences, Portland Oregon)",0.9,Accept,Experimental Usage
RESe69ab1ae,Human Protein Atlas (proteinatlas.org),Database,23.0,,,,,,,Human Protein Atlas (proteinatlas.org),PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Subcellular localization was assessed for the PPI's using the Human Protein Atlas (proteinatlas.org) Subcellular section (Protein Atlas version 23.0),0.9,Accept,Experimental Usage
RES53cd6f66,QIAGEN Ingenuity Pathway Analysis (IPA),Analysis Software,,,,,,,,QIAGEN Ingenuity Pathway Analysis (IPA),PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Further Pathway analysis was conducted using QIAGEN Ingenuity Pathway Analysis (IPA),0.9,Accept,Experimental Usage
RES36941219,Partek Flow software (v.9.0),Analysis Software,v.9.0,,,,,,,Partek Flow software (v.9.0),PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"The analysis for this Article was generated using Partek Flow software, v.9.0",0.9,Accept,Experimental Usage
RESa6ec65fb,STAR (v.2.7.3a),Analysis Software,v.2.7.3a,,,,,,,STAR (v.2.7.3a),PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,RNA-seq reads were aligned to the Ensembl release 100 top-level assembly with STAR v.2.7.3a,0.9,Accept,Experimental Usage
RES3cb0d20e,Cell Profiler (v.3.1.9),Analysis Software,v.3.1.9,,,,,,,Cell Profiler (v.3.1.9),PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Cell proliferation was determined by dividing the number of EdU+ cells by the number of DAPI+ cells using Cell Profiler (v.3.1.9),0.9,Accept,Experimental Usage
RES236c3ef8,Stereo Investigator software (mbfbioscience v2019),Analysis Software,v2019,,,,,,,Stereo Investigator software (mbfbioscience v2019),PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Images were taken using a Zeiss Axio Imager M2 and the Stereo Investigator software (mbfbioscience v2019),0.9,Accept,Experimental Usage
RESe04fef7b,Image Lab software (v.6),Analysis Software,v.6,,,,,,,Image Lab software (v.6),PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,imaged on a Bio-Rad Gel Doc imager using Image Lab software (v.6),0.9,Accept,Experimental Usage
RESf8dd2655,Image Studio Lite (v.5.0.21),Analysis Software,v.5.0.21,,,,,,,Image Studio Lite (v.5.0.21),PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,and analysed using Image Studio Lite (v.5.0.21),0.9,Accept,Experimental Usage
RES91bb3586,origin8.1,Analysis Software,8.1,,,,,,,origin8.1,PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Analysis was performed using Fitmaster and origin8.1 (OriginLab Corporation, MA)",0.85,Accept,Experimental Usage
RES061c2253,Nikon Elements software,Analysis Software,,,,,,,,Nikon Elements software,PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,The morphometric analysis of neurite lengths of transfected green fluorescent cells was performed with Nikon Elements software,0.9,Accept,Experimental Usage
RESc817b20b,BWA-MEM v 0.7.12,Command-line Tool,v 0.7.12,,,,,,,BWA-MEM v 0.7.12,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,read pairs were aligned to the hg19 reference genome using BWA-MEM v 0.7.12 with default parameters,0.9,Accept,Experimental Usage
RESfa7ea4cc,GATK v3.6.0,Command-line Tool,v3.6.0,,,,,,,GATK v3.6.0,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"PCR duplicate marking, indel realignment and base quality score recalibration were performed using Picard v1.72 and GATK v3.6.0",0.9,Accept,Experimental Usage
RES9e79c59c,Mutect V1.1.6,Command-line Tool,V1.1.6,,,,,,,Mutect V1.1.6,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,We identified somatic mutations using Mutect V1.1.6 and Strelka v1.0.13 for 20 tumors with matched peripheral blood controls,0.9,Accept,Experimental Usage
RESd3d40c00,Strelka v1.0.13,Command-line Tool,v1.0.13,,,,,,,Strelka v1.0.13,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,We identified somatic mutations using Mutect V1.1.6 and Strelka v1.0.13 for 20 tumors with matched peripheral blood controls,0.9,Accept,Experimental Usage
RES46762b5e,STAR aligner (v.2.6.0),Command-line Tool,v.2.6.0,,,,,,,STAR aligner (v.2.6.0),PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Sequence data was processed and aligned to human reference genome (hg38) using STAR aligner (v.2.6.0),0.9,Accept,Experimental Usage
RES414d06fd,FusionCatcher v1.1.0,Command-line Tool,v1.1.0,,,,,,,FusionCatcher v1.1.0,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Fusion genes for cohort of PNSTs were identified using FusionCatcher v1.1.0 with default parameters,0.9,Accept,Experimental Usage
RES2f917537,Seurat version 3.0,Package/Library,version 3.0,R,,,,,,Seurat version 3.0,PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"The raw gene expression matrix was normalized, and variance stabilized by SCTransform in Suerat version 3.0",0.9,Accept,Experimental Usage
RES1177b3f0,inferCNV (v.1.1.1),Package/Library,v.1.1.1,R,,,,,,inferCNV (v.1.1.1),PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,CNAs of neoplastic and non-neoplastic cells were inferred from the snRNA-seq data using inferCNV (v.1.1.1),0.9,Accept,Experimental Usage
RES1c26bcde,limma package,Package/Library,,R,,,,,,limma package,PMID:23175151 | PMID:34010628 | PMID:28256556 | PMID:23535903,10.1038/bjc.2012.518 | 10.1016/j.stem.2021.04.029 | 10.1038/srep43315 | 10.1158/2159-8290.CD-13-0081,"MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression. | Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression. | An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,The limma package was also used for differential expression and multiple testing was controlled using the false discovery rate | Limma package was used for generating the human 621-MPNST signature | The Bioconductor/R limma package was used to define DEGs between two groups | Statistical comparisons were done using R/Bioconductor's Limma package ( http://www.bioconductor.org ),0.9,Accept,Experimental Usage
RES9d6618c0,GeneSpring GX v7.3.1,Analysis Software,v7.3.1,,,,,,,GeneSpring GX v7.3.1,PMID:23685747 | PMID:23535903,10.1038/ng.2641 | 10.1158/2159-8290.CD-13-0081,"Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. | Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,Statistical comparisons were done using R/Bioconductor packages and GeneSpring GX v7.3.1 (Agilent Technologies) | Statistical comparisons were done using R/Bioconductor's Limma package ( http://www.bioconductor.org ) and GeneSpring GXv7.3.1 (Agilent Technologies),0.9,Accept,Experimental Usage
RES001192a1,"Matlab script (Version 9.9.0, Natick, MA)",Analysis Software,9.9.0,MATLAB,,,,,,"Matlab script (Version 9.9.0, Natick, MA)",PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,"The SSTMean method consisted of 4 main steps that were implemented in a Matlab script (Version 9.9.0, Natick, MA).",0.85,Accept,Development
RES430c2678,SSTMean,Analysis Software,,,,,,,,SSTMean,PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,A semi-automatic segmentation technique based on mean magnetic resonance imaging (MRI) intensity thresholding (SSTMean) was developed,0.9,Accept,Development
RES949c580f,fastp v.0.2,Analysis Software,v.0.2,,,,,,,fastp v.0.2,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,raw reads were quality filtered using fastp v.0.2,0.9,Accept,Experimental Usage
RES96aa8c5f,BWA v.0.7.17,Analysis Software,v.0.7.17,,,,,,,BWA v.0.7.17,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,Quality-filtered reads were then aligned to the hg19 human genome assembly using BWA v.0.7.17,0.9,Accept,Experimental Usage
RESa0737fb1,Samtools v.1.7,Analysis Software,v.1.7,,,,,,,Samtools v.1.7,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,Aligned reads were deduplicated with Samtools v.1.7,0.9,Accept,Experimental Usage
RES00d6a02d,ichorCNA tool (Broad v.0.2.0),Analysis Software,v.0.2.0,,,,,,,ichorCNA tool (Broad v.0.2.0),PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,copy number–based estimation of tumor fraction were then performed using the ichorCNA tool (Broad v.0.2.0),0.95,Accept,Experimental Usage
RESfade5453,deepTools bamPEFragmentSize,Analysis Software,,,,,,,,deepTools bamPEFragmentSize,PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,read-pair fragment sizes for cfDNA samples were calculated using deepTools bamPEFragmentSize,0.9,Accept,Experimental Usage
RESd417d523,CRISPOR software,Web Application,,,http://crispor.tefor.net,,,,,CRISPOR software,PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Single-guide RNAs (sgRNAs) were designed using CRISPOR software (http://crispor.tefor.net),0.9,Accept,Experimental Usage
RES84e3bf74,AnyMaze software,Analysis Software,,,,,,,,AnyMaze software,PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,The time spent near each wire cup was recorded and scored with the automated AnyMaze software,0.9,Accept,Experimental Usage
REScef0bba5,SPSS 18,Analysis Software,18,,,,,,,SPSS 18,PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,"Statistical analyses were done using SPSS 18 version for Windows (SPSS Inc., Chicago IL, USA)",0.9,Accept,Experimental Usage
RES4473da16,SAS 9.3,Analysis Software,9.3,,,,,,,SAS 9.3,PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,"Statistical analyses were done using SPSS 18 version for Windows (SPSS Inc., Chicago IL, USA) and SAS 9.3 version for Windows (SAS Institute Inc., Cary, NC, USA)",0.9,Accept,Experimental Usage
RESb82659a0,UCSF500 NGS Panel,Analysis Software,,,,,,,,UCSF500 NGS Panel,PMID:35945463,10.1007/s00401-022-02478-5,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.,,Targeted next-generation sequencing was performed using the UCSF500 NGS Panel as previously described,0.9,Accept,Experimental Usage
RESd1a60b59,Rtsne,Package/Library,v.0.15,R,,,,,,Rtsne,PMID:35945463 | PMID:33025139,10.1007/s00401-022-02478-5 | 10.1007/s00401-020-02230-x,"Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Dimensionality reduction using t-distributed stochastic neighbor embedding (tSNE) was performed by Rtsne (v.0.15) | We used Rtsne package in Bioconductor to generate tSNE plots based on the top 10,000 most variably methylated CpG sites",0.9,Accept,Experimental Usage
RESbfcaebef,ComplexHeatmap,Package/Library,v.2.8.0,R,,,,,,ComplexHeatmap,PMID:35945463 | PMID:39093127,10.1007/s00401-022-02478-5 | 10.1158/1078-0432.CCR-24-0797,Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.,,Visualization was performed using the R package ComplexHeatmap (v.2.8.0) | were represented by heatmaps using ComplexHeatmap (v.2.14.0) with supervised clustering,0.9,Accept,Experimental Usage
RES7b858888,Prism 4.0,Analysis Software,4.0,,,,,,,Prism 4.0,PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Graphing and statistical analysis was performed with Prism 4.0 (GraphPad Software, La Jolla, CA)",0.85,Accept,Experimental Usage
RESa66dc0ff,AlphaFold 3,Web Application,,,,,,,,AlphaFold 3,PMID:40191916 | PMID:39373898,10.1093/g3journal/jkaf067 | 10.1007/s12031-024-02271-x,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool. | Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.",,"The WMSTM and human amino acid sequences were then input into AlphaFold 3 for structural predictions | we utilized AlphaFold3 to simulate both the wild-type and mutant NF1 structures, revealing the significant effects",0.9,Accept,Experimental Usage
RESe35e423b,Smart-seq2,Pipeline,,,,,,,,Smart-seq2,PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"Smart-seq2 whole transcriptome amplification, library construction, and sequencing were performed as previously published",0.9,Accept,Experimental Usage
RESfd3f0ced,scdDblFinder,Package/Library,,R,,,,,,scdDblFinder,PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Doublets were identified by combining the results of two methods that were published recently and implemented in R packages—scdDblFinder,0.9,Accept,Experimental Usage
RESa86320d5,scran,Package/Library,,R,,,,,,scran,PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,scdDblFinder and the doubletCells algorithm from scran,0.9,Accept,Experimental Usage
RESf0ae0253,QuPath,Analysis Software,,,,,,,,QuPath,PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Quantification of staining intensity was performed in QuPath,0.9,Accept,Experimental Usage
RESb36323be,cBioPortal,Web Application,,,,,,,,cBioPortal,PMID:33507258 | PMID:39472976 | PMID:41564118,10.1001/jamanetworkopen.2020.35479 | 10.1186/s40478-024-01875-z | 10.1371/journal.pone.0340183,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases. | NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes. | Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,databases in cBioPortal including TCGA (The Cancer Genome Atlas) | The cBioportal website (cbioportal.org) was used to analyze The Cancer Genome Atlas (TCGA)—Firehose Legacy | Somatic variants were queried in cBioPortal (https://www.cbioportal.org/),0.9,Accept,Experimental Usage
RES3cf5ecfe,Seurat,Package/Library,5.3.0,R,https://satijalab.org/seurat/,,,,,Seurat,PMID:41591566 | PMID:33591953 | PMID:38216587,10.1007/s00401-026-02979-7 | 10.1172/jci.insight.146351 | 10.1038/s41467-023-40408-5,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. | Chromosome 8 gain is associated with high-grade transformation in MPNST. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,"We processed the data using Seurat (Version: 5.3.0, https://satijalab.org/seurat/) in R (Version: 4.4.0) | filtered_feature_bc_matrix was imported using the Read10X function in Seurat (version 3.0) | Data were normalized, and variance stabilized by SCTransform in Seurat version 3.0",0.95,Accept,Experimental Usage
RES01c7dd19,CellRanger,Analysis Software,,,,,,,,CellRanger,PMID:37770931 | PMID:33591953 | PMID:38216587,10.1186/s40478-023-01639-1 | 10.1172/jci.insight.146351 | 10.1038/s41467-023-40408-5,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas. | Chromosome 8 gain is associated with high-grade transformation in MPNST. | Epigenetic reprogramming shapes the cellular landscape of schwannoma.",,"Raw sequencing reads were processed using CellRanger (10 × Genomics) | The standard 10X Genomics Cell Ranger (version 3.1.0) pipeline was used to extract FASTQ files | Library demultiplexing, read alignment to human genome GRCh38, and unique molecular identifier (UMI) quantification was performed in Cell Ranger version 1.3.1",0.9,Accept,Experimental Usage
RES334e5156,Signac,Package/Library,1.8.0,R,,,,,,Signac,PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,Preprocessing of single-nuclei RNA and ATAC data was performed using Signac v1.8.0,0.85,Accept,Experimental Usage
RESa5af335f,caret,Package/Library,6.0,R,,,,,,caret,PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,,a methylation-based classifier using differentially methylated probes from our discovery cohort of 66 tumors was used to construct a support vector machine (SVM) using caret version 6.0 in R version 3.6.0,0.85,Accept,Experimental Usage
RESbff2231d,Aardex MEMS Adherence Software (ElectronReader 0.9.9),Analysis Software,0.9.9,,,,,,,Aardex MEMS Adherence Software (ElectronReader 0.9.9),PMID:39858077,10.3390/cancers17020295,A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib.,,"diaries and pill bottles (including empty ones) were collected, and MEMS TM cap data were uploaded to Aardex MEMS TM Adherence Software (ElectronReader 0.9.9).",0.85,Accept,Experimental Usage
RES97c08f58,NanoDrop 2000,Analysis Software,,,,,,,,NanoDrop 2000,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Purity of DNA was assessed by spectrophotometry using NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA, USA)",0.9,Accept,Experimental Usage
RES7913b4f8,Ion Torrent Personal Genome Machine—Ion Torrent PGM™,Analysis Software,,,,,,,,Ion Torrent Personal Genome Machine—Ion Torrent PGM™,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,NGS was performed on Ion Torrent Personal Genome Machine—Ion Torrent PGM™ (Thermo Fisher Scientific),0.95,Accept,Experimental Usage
RES3c41ec66,Torrent Suite software,Analysis Software,,,,,,,,Torrent Suite software,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,Primary analyses of NGS data were performed using Torrent Suite software on the Ion Torrent Browser,0.9,Accept,Experimental Usage
RES68b405f5,Ingenuity Variant Analysis software,Analysis Software,,,,,,,,Ingenuity Variant Analysis software,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"For variant interpretation, Ingenuity ® Variant Analysis™ software (Qiagen) and SNPnexus web server were used",0.9,Accept,Experimental Usage
RESe64cb580,Integrative Genomics Viewer,Analysis Software,2.3.40,,,,,,,Integrative Genomics Viewer,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Variants were also viewed manually on Integrative Genomics Viewer (IGV—version 2.3.40; Broad Institute, Cambridge, MA, USA)",0.9,Accept,Experimental Usage
RES4aff662f,Alamut Visual,Analysis Software,2.6.1e,,,,,,,Alamut Visual,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"on Alamut ® Visual (version 2.6.1e; Interactive Biosoftware, Rouen, France) to eliminate strand bias and reduce false positive calls",0.9,Accept,Experimental Usage
RES60889c90,Human Splicing Finder,Web Application,,,,,,,,Human Splicing Finder,PMID:40887659 | PMID:27999334,10.1186/s40246-025-00803-z | 10.3390/genes7120133,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity. | Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,with the Human Splicing Finder (HSF; http://www.umd.be/HSF/) | we also used the online Human Splicing Finder ( http://www.umd.be/HSF/ ),0.9,Accept,Experimental Usage
RES6e1d2bb9,AB3130 Genetic Analyzer,Analysis Software,,,,,,,,AB3130 Genetic Analyzer,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"All variants were confirmed by Sanger sequencing in an AB3130 Genetic Analyzer (Applied Biosystems, Carlsbad, CA, USA)",0.9,Accept,Experimental Usage
RESc2ca7256,Sequencing Analysis software,Analysis Software,5.4,,,,,,,Sequencing Analysis software,PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,the sequences were analyzed with the Sequencing Analysis software (version 5.4; Applied Biosystems),0.85,Accept,Experimental Usage
RESb0e64f59,FlowJo 7.6.5,Analysis Software,7.6.5,,,,,,,FlowJo 7.6.5,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...analyzed with FACSDiva (BD Biosciences) or FlowJo 7.6.5 ( FlowJo.com ; Tree Star, OR, USA) software...",0.9,Accept,Experimental Usage
RES901801c4,SPSS v. 20.0,Analysis Software,v. 20.0,,,,,,,SPSS v. 20.0,PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Statistical analysis was performed using Statistical Package for Social Sciences software (SPSS v. 20.0; Chicago, IL, USA)...",0.8,Accept,Experimental Usage
RESf69bc52a,ChAMP,Package/Library,v2.18.3,R,,,,,,ChAMP,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Data were analyzed using a modified workflow that is similar to the ChAMP methylation array analysis procedure in R (v3.5.1),0.9,Accept,Experimental Usage
RES4e13ca45,glmmTMB,Package/Library,v0.2.2,R,,,,,,glmmTMB,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Differentially methylated loci between cutaneous and plexiform neurofibromas were identified using a hierarchical generalized linear mixed model (GLMM) approach with a logit link function as implemented in glmmTMB (v0.2.2),0.85,Accept,Experimental Usage
RES70663c0d,DMRcate,Package/Library,v1.18.0,R,,,,,,DMRcate,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Differentially methylated regions were called using DMRcate (v1.18.0),0.85,Accept,Experimental Usage
RES4ac257d6,compartmap,Package/Library,v1.65.71,R,,,,,,compartmap,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Chromatin compartments were computed at 100 kb resolution as previously described and implemented in compartmap (v1.65.71),0.85,Accept,Experimental Usage
RES75091580,missMethyl,Package/Library,v1.16.0,R,,,,,,missMethyl,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Enrichment of pathways and gene ontology (GO) terms was performed using the gometh function within the missMethyl (v1.16.0) package in R,0.85,Accept,Experimental Usage
RESf910f1bf,PAMES,Package/Library,v0.2.3,R,,,,,,PAMES,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Tissue purity was estimated by PAMES (v0.2.3),0.85,Accept,Experimental Usage
RES25b63c76,SeSAMe,Package/Library,v1.3.2,R,,,,,,SeSAMe,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Copy number alterations were computed using SeSAMe (v1.3.2) with minor modifications for plotting functionality,0.85,Accept,Experimental Usage
RESfdf38176,betareg,Package/Library,v3.1-2,R,,,,,,betareg,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Pairwise comparisons of beta-regressions calculated by betareg (v3.1–2),0.85,Accept,Experimental Usage
RESb30b7906,emmeans,Package/Library,v1.4.2,R,,,,,,emmeans,PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Pairwise comparisons of beta-regressions calculated by betareg (v3.1–2) were done using emmeans (v1.4.2),0.85,Accept,Experimental Usage
RESef16f7b7,MACS version 1.4.2,Analysis Software,1.4.2,,,,,,,MACS version 1.4.2,PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,peak calling was performed using Model-based analysis of ChIP-seq (MACS) version 1.4.2 ( http://liulab.dfci.harvard.edu/MACS ) with default parameters,0.9,Accept,Experimental Usage
RESb8c2cb42,3D Slicer,Analysis Software,5.6.2,,https://www.slicer.org/,,,,,3D Slicer,PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"The two readers independently performed three-dimensional selection of the volume of interest by manual segmentation of the DRG of levels L5 and S1 via 3D Slicer (The Slicer Community 2024: 3D Slicer, version 5.6.2)",0.9,Accept,Experimental Usage
RESc7e32f51,SimNIBS 3.2,Analysis Software,3.2,,https://simnibs.github.io/simnibs/build/html/index.html,,,,,SimNIBS 3.2,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,SimNIBS 3.2 ( https://simnibs.github.io/simnibs/build/html/index.html ) was used to estimate the electric field induced by tDCS,0.9,Accept,Experimental Usage
RES57663886,SPM8,Analysis Software,8,,http://www.fil.ion.ucl.ac.uk/spm/,,,,,SPM8,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"the T1-weighted anatomical images were segmented into gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF) using SPM8",0.9,Accept,Experimental Usage
RES7259dcf4,jMRUI5.1,Analysis Software,5.1,,,,,,,jMRUI5.1,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Quantification was conducted using the Advanced Magnetic Resonance (AMARES) routine in the Java-based magnetic resonance user's interface (jMRUI5.1, EU project)",0.9,Accept,Experimental Usage
RES76201fc1,SPM12,Analysis Software,12,,http://www.fil.ion.ucl.ac.uk/spm,,,,,SPM12,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Image processing and statistical analysis was carried out using SPM12 (Wellcome Department of Imaging Neuroscience, London)",0.9,Accept,Experimental Usage
RES86e520b0,Psychopy2,Analysis Software,2,,,,,,,Psychopy2,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,Psychopy2 software was used to display the stimuli and to record responses,0.85,Accept,Experimental Usage
RES82eea37a,SPSS version25,Analysis Software,25,,,,,,,SPSS version25,PMID:36316421 | PMID:33519543 | PMID:37608248,10.1038/s41598-022-21907-9 | 10.3389/fpsyt.2020.585700 | 10.1186/s11689-023-09492-y,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1. | Autism Spectrum Disorder Symptom Profile Across the RASopathies. | Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,"Statistical analyses were performed in SPSS version25 and R version 1.2 | Data were analyzed in SPSS version 25 (SPSS Inc., Chicago, USA) | Statistical analyses were conducted using SPSS (Version 25)",0.85,Accept,Experimental Usage
RES9465b434,MATLAB R2014a,Analysis Software,R2014a,MATLAB,,,,,,MATLAB R2014a,PMID:36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,,"Image processing and statistical analysis was carried out using SPM12 (Wellcome Department of Imaging Neuroscience, London; http://www.fil.ion.ucl.ac.uk/spm ) and MATLAB R2014a",0.85,Accept,Experimental Usage
RES67975715,Imaris × 64 version 9.6–9.9,Analysis Software,9.6–9.9,,,,,,,Imaris × 64 version 9.6–9.9,PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"3-dimensional fluorescence images using Imaris × 64 version 9.6–9.9 (Bitplane, Zurich, Switzerland) algorithms",0.95,Accept,Experimental Usage
RES61bc1580,IGOR Pro 6.37,Analysis Software,6.37,,,,,,,IGOR Pro 6.37,PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"IGOR Pro 6.37 (Lake Oswego, USA) was used for data analysis",0.9,Accept,Experimental Usage
RES97a24144,Prism 7,Analysis Software,7,,,,,,,Prism 7,PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"one-way ANOVA tests with Bonferroni post hoc tests were employed using Prism 7 (GraphPad Software, San Diego, CA, USA)",0.9,Accept,Experimental Usage
RES179fc3f7,wANNOVAR web server,Web Application,,,,,,,,wANNOVAR web server,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"We used wANNOVAR web server to annotate and prioritize variants, identified candidate genes with recurrent mutations",0.9,Accept,Experimental Usage
RESff2fbb59,SeqMule,Pipeline,,,http://seqmule.usc.edu/,,,,,SeqMule,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,We used SeqMule (http://seqmule.usc.edu/) pipeline as our primary variant calling pipeline.,0.9,Accept,Experimental Usage
RESb4b66cb8,Codon Code Aligner,Analysis Software,,,http://www.codoncode.com/aligner/,,,,,Codon Code Aligner,PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,The sequencing traces were manually visualized in Codon Code Aligner software (http://www.codoncode.com/aligner/) to confirm the presence of candidate mutations.,0.85,Accept,Experimental Usage
RES6048c50f,primer 3 (v. 0.4.0),Web Application,v. 0.4.0,,http://bioinfo.ut.ee/primer3-0.4.0/,,,,,primer 3 (v. 0.4.0),PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,Twelve pairs of primers were designed using primer 3 (v. 0.4.0) (http://bioinfo.ut.ee/primer3-0.4.0/).,0.9,Accept,Experimental Usage
RESa8d7554f,Stratagene Mx3005 – MxPro QPCR-Software,Analysis Software,2007,,,,,,,Stratagene Mx3005 – MxPro QPCR-Software,PMID:27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,,"Genotyping was performed using a real-time PCR system in the allelic discrimination mode (Stratagene Mx3005 – MxPro QPCR-Software, 2007)",0.8,Accept,Experimental Usage
RES167749d1,SPSS 20.0,Analysis Software,20.0,,,,,,,SPSS 20.0,PMID:32733557 | PMID:27458360,10.1155/2020/5976465 | 10.3389/fnhum.2016.00334,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis. | COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.",,Statistical analysis was conducted by SPSS 20.0 software. | All statistical procedures were performed in SPSS 20.0,0.8,Accept,Experimental Usage
RESafc66339,Incucyte S3 Live-Cell Analysis System,Analysis Software,,,,,,,,Incucyte S3 Live-Cell Analysis System,PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"The total integrated intensity of RFP was monitored over the course of 72 hours, taking measurements every 2 hours with the Incucyte S3 Live-Cell Analysis System (Sartorius, Gottingen, Germany)",0.9,Accept,Experimental Usage
RES1e28a6e3,"ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",Analysis Software,1.1,,,,,,,"ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"cDNA samples were then subjected to qPCR amplification on an ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",0.85,Accept,Experimental Usage
RES76cba507,SPSS 17.0,Analysis Software,17.0,,,,,,,SPSS 17.0,PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,Statistical analysis was performed using the SPSS 17.0 statistics software,0.8,Accept,Experimental Usage
RESbcb790bc,SPSS 12.0,Analysis Software,12.0,,,,,,,SPSS 12.0,PMID:18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,,"All data were analyzed using SPSS 12.0 (SPSS Inc, Chicago, Illinois)",0.8,Accept,Experimental Usage
RESa32aa787,Mutalyzer 2.0,Web Application,2.0,,,,,,,Mutalyzer 2.0,PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...the online batch position check tool Mutalyzer 2.0 (http://www.mutalyzer.nl/) was used to confirm genomic position of all SPRED1 gene variants...,0.9,Accept,Experimental Usage
RES62cafc7a,FusionCharts v3,Analysis Software,v3,,,,,,,FusionCharts v3,PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...Graphics were generated using FusionCharts v3 (www.fusioncharts.com)...,0.9,Accept,Experimental Usage
RESaeeff30d,DESeq2 (version 1.12.4),Package/Library,1.12.4,R,,,,,,DESeq2 (version 1.12.4),PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,DESeq2 (version 1.12.4) was used to determine differentially expressed genes (DEGs) between two samples,0.9,Accept,Experimental Usage
RES4d05f59a,PRISM (version 8),Analysis Software,8,,,,,,,PRISM (version 8),PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,"Statistical analyses were conducted with PRISM (version 8, GraphPad Software, Inc., San Diego, CA, USA)",0.8,Accept,Experimental Usage
RES3861baca,Volocity software (Version 7.0.0),Analysis Software,7.0.0,,,,,,,Volocity software (Version 7.0.0),PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Image stacks were processed and reconstructed in 3D using Volocity software (Version 7.0.0; PerkinElmer, Waltham, MA, USA) for visualization and quantification",0.9,Accept,Experimental Usage
RES0603bab8,Insight Toolkit,Package/Library,,,www.itk.org/,,,,,Insight Toolkit,PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,The pipeline for PN identification was developed in-house using the Insight Toolkit ( www.itk.org/ ) interfacing with the medical imaging visualization suite,0.85,Accept,Experimental Usage
RESee73e1aa,Slicer,Analysis Software,,,www.slicer.org/,,,,,Slicer,PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,"using the Insight Toolkit ( www.itk.org/ ) interfacing with the medical imaging visualization suite, Slicer ( www.slicer.org/ )",0.85,Accept,Experimental Usage
RES925012df,RELION,Analysis Software,,C++,,,,,,RELION,PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,,Data processing was done using the RELION (32) software package.,0.9,Accept,Experimental Usage
RES0be0cd5a,bwa-mem v0.7.10,Analysis Software,v0.7.10,,,,,,,bwa-mem v0.7.10,PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,Sequence reads were aligned to the reference sequence (GRCh37) using bwa‐mem v0.7.10,0.95,Accept,Experimental Usage
RES8688e782,"GATK, version 1.0.4705",Analysis Software,1.0.4705,,,,,,,"GATK, version 1.0.4705",PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,"followed by variant calling using GATK, version 1.0.4705",0.95,Accept,Experimental Usage
RESeec28b26,VisCap,Analysis Software,,,,,,,,VisCap,PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,Copy number variants (CNVs) were identified via an NGS‐based detection tool (VisCap),0.9,Accept,Experimental Usage
RESaff2e8aa,Trimmomatic v 0.39,Analysis Software,v 0.39,,,,,,,Trimmomatic v 0.39,PMID:37246765 | PMID:38000020,10.1093/neuonc/noad097 | 10.1126/sciadv.adg8876,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,WES sequencing FASTQ files were trimmed using Trimmomatic v 0.39 | Whole-exome sequencing FastQ files were trimmed by using Trimmomatic v 0.39,0.9,Accept,Experimental Usage
RES4747ca13,GATK V4.2,Analysis Software,V4.2,,,,,,,GATK V4.2,PMID:37246765 | PMID:38000020,10.1093/neuonc/noad097 | 10.1126/sciadv.adg8876,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,GATK V4.2 base quality score recalibration (BQSR) was used to process BAM files | Genomic analysis toolkit (GATK) V4.2 base quality score recalibration was also used to process BAM files,0.9,Accept,Experimental Usage
RESea0d817d,FlowJo 10.8,Analysis Software,10.8,,,,,,,FlowJo 10.8,PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,"Data analysis was performed using FlowJo 10.8, and cell cycle distribution was assigned by using the implemented models",0.8,Accept,Experimental Usage
RES58619969,Cell Ranger pipeline v7.1.0,Pipeline,v7.1.0,,,,,,,Cell Ranger pipeline v7.1.0,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,resulting sequencing files were run through the Cell Ranger pipeline v7.1.0,0.9,Accept,Experimental Usage
RESde557bb6,Seurat v4.3.0–v5,Package/Library,v4.3.0–v5,R,,,,,,Seurat v4.3.0–v5,PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,"Data analysis was completed using R (v 4.3.0–v 4.3.1) Seurat [ 24 ,  25 ] (v4.3.0–v5)",0.9,Accept,Experimental Usage
RES12c4aa69,Ingenuity Pathway Analysis (IPA),Analysis Software,,,,,,,,Ingenuity Pathway Analysis (IPA),PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",,Ingenuity pathway analysis (IPA) was also used to identify pathways that differ on treatment,0.9,Accept,Experimental Usage
RESe4975c67,Illumina CASAVA software (v1.8),Analysis Software,v1.8,,,,,,,Illumina CASAVA software (v1.8),PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"primary processing of sequence data for both tumor and normal samples were performed using Illumina CASAVA software (v1.8), including masking of adapter sequences.",0.9,Accept,Experimental Usage
RES94c54c9d,RealSeqS,Analysis Software,,,https://zenodo.org/record/3656943#.YaZZCdDMKUk.32,,,,,RealSeqS,PMID:35244537,10.7554/eLife.74238,Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.,,"RealSeqS uses a single primer pair to amplify about 750,000 loci scattered throughout the genome",0.9,Accept,Experimental Usage
RESf331535b,BWA version 0.7.15,Command-line Tool,0.7.15,,,,,,,BWA version 0.7.15,PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"The sequenced reads were mapped to the hg19 by Burrows-Wheeler Aligner (BWA version 0.7.15, default parameters, BWA-MEM algorithm)",0.85,Accept,Experimental Usage
RES126af7cf,GATK MuTect2 (version 4.1),Analysis Software,4.1,,,,,,,GATK MuTect2 (version 4.1),PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Mutations were identified via GATK MuTect2 (version 4.1, default parameters)",0.85,Accept,Experimental Usage
RES31ec30b7,ANNOVAR (version 2016-02-01),Analysis Software,2016-02-01,,,,,,,ANNOVAR (version 2016-02-01),PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Mutations were annotated with software ANNOVAR (version 2016-02-01, default parameters)",0.85,Accept,Experimental Usage
RES643a426c,SAS 9.4,Analysis Software,9.4,,,,,,,SAS 9.4,PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"All statistical analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC)",0.85,Accept,Experimental Usage
RES3ce85f96,ParaVision 6.0.1,Analysis Software,6.0.1,,,,,,,ParaVision 6.0.1,PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"B-GA12S HP gradients running ParaVision 6.0.1, Bruker BioSpin",0.85,Accept,Experimental Usage
RES21a98b80,Trimmomatic (v0.33),Analysis Software,v0.33,,,,,,,Trimmomatic (v0.33),PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,quality trimming via Trimmomatic (v0.33),0.85,Accept,Experimental Usage
RES533e0905,HISAT2 (v2.1.0),Analysis Software,v2.1.0,,,,,,,HISAT2 (v2.1.0),PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,alignment via HISAT2 (v2.1.0),0.85,Accept,Experimental Usage
RES52735890,StringTie (v1.3.4d),Analysis Software,v1.3.4d,,,,,,,StringTie (v1.3.4d),PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,gene count quantification via StringTie (v1.3.4d),0.85,Accept,Experimental Usage
RES1bb25a42,DESeq2 (v1.42.0),Package/Library,v1.42.0,R,,,,,,DESeq2 (v1.42.0),PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"Differential expression analysis was performed using R statistical software (v4.3.1), tidyverse (v2.0.0), and DESeq2 (v1.42.0)",0.85,Accept,Experimental Usage
RESa4bb8503,GeneAnalytics(v),Web Application,v,,,,,,,GeneAnalytics(v),PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,Pathway analysis was performed using GeneAnalytics(v),0.8,Accept,Experimental Usage
RESc3d28d93,Bruker AutoFlex III mass spectrometer,Analysis Software,,,,,,,,Bruker AutoFlex III mass spectrometer,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"MALDI IMS experiments were performed on a Bruker AutoFlex III mass spectrometer (Bruker Daltonics Billerica, MA, USA)",0.9,Accept,Experimental Usage
RES4d81973b,FlexImaging 4.0,Analysis Software,4.0,,,,,,,FlexImaging 4.0,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,The 2-D IMS data sets were collected using FlexImaging 4.0 (Bruker Daltonics),0.9,Accept,Experimental Usage
RESd36d0c89,Thermo LTQ Velos Orbitrap mass spectrometer,Analysis Software,,,,,,,,Thermo LTQ Velos Orbitrap mass spectrometer,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"LC-MS/MS experiments were performed on a Thermo LTQ Velos Orbitrap mass spectrometer (Thermo Scientific, Waltham, MA, USA)",0.9,Accept,Experimental Usage
RESfc49471c,TagIdent,Web Application,,,http://web.expasy.org/tagident/,,,,,TagIdent,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,sequence tags of around 4–5 amino acids that were subsequently searched using TagIdent (http://web.expasy.org/tagident/),0.85,Accept,Experimental Usage
RESe64badd8,protein prospector MS-product,Web Application,,,http://prospector.ucsf.edu/prospector/mshome.htm,,,,,protein prospector MS-product,PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,Proteins with matching intact molecular weights and containing the sequence observed were processed using protein prospector MS-product (http://prospector.ucsf.edu/prospector/mshome.htm),0.85,Accept,Experimental Usage
RES40bea778,GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0,Analysis Software,,,,,,,,GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0,PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,These microarray data were based on GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version],0.9,Accept,Experimental Usage
RESa1c770d0,Bioconductor limma package,Package/Library,,R,,,,,,Bioconductor limma package,PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,The Bioconductor limma package [20] was used to preprocess the expression data from Human Genome U133 Plus 2.0 Affymetrix Array,0.9,Accept,Experimental Usage
RES864653f7,Volocity software 7.0.0,Analysis Software,7.0.0,,,,,,,Volocity software 7.0.0,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Images were reconstructed in 3D using Volocity software 7.0.0 (PerkinElmer, Waltham, MA, USA)",0.9,Accept,Experimental Usage
RESae940927,Nanoparticle Tracking Analysis software version 3.3 Dev Build 3.3.104,Analysis Software,3.3 Dev Build 3.3.104,,,,,,,Nanoparticle Tracking Analysis software version 3.3 Dev Build 3.3.104,PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"sEV depletion was determined by version 3.3 Dev Build 3.3.104 Nanoparticle Tracking Analysis software (Malvern Panalytical Ltd., Malvern, UK)",0.9,Accept,Experimental Usage
RES066a9860,Oligo 5.0 computer program,Analysis Software,5.0,,,,,,,Oligo 5.0 computer program,PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,"Primers for TBP, RPLP0 and the 489 target genes (List in annex; supplementary information) were chosen with the assistance of the Oligo 5.0 computer program (National Biosciences, Plymouth, MN)",0.85,Accept,Experimental Usage
RES3763a7a0,R 4.4.2 software,Analysis Software,4.4.2,R,,,,,,R 4.4.2 software,PMID:40529476,10.1016/j.xjidi.2025.100380,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,,"Statistical analyses were performed using R 4.4.2 software (R Foundation for Statistical Computing, Vienna, Austria)",0.8,Accept,Experimental Usage
RES3c6ede92,Sci-kit Learn,Package/Library,,Python,,,,,,Sci-kit Learn,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used python 3.5.1 and Sci-kit Learn for machine learning implementations,0.9,Accept,Experimental Usage
RESeeb4a0f7,python 3.5.1,Analysis Software,3.5.1,Python,,,,,,python 3.5.1,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used python 3.5.1 and Sci-kit Learn for machine learning implementations,0.85,Accept,Experimental Usage
RES442ce25a,Li-COR Image Studio Lite 5.0,Analysis Software,5.0,,,,,,,Li-COR Image Studio Lite 5.0,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,Densitometry was performed using Li-COR Image Studio Lite 5.0,0.9,Accept,Experimental Usage
RES5afa76e3,nf1_inactivation GitHub repository,Pipeline,,,https://github.com/greenelab/nf1_inactivation,,,,,nf1_inactivation GitHub repository,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"All source code is available under a permissive open source license in the nf1_inactivation GitHub repository, https://github.com/greenelab/nf1_inactivation",0.95,Accept,Development
RESb1ae57ff,GeneChip Human Transcriptome Array 2.0,Other,,,,,,,,GeneChip Human Transcriptome Array 2.0,PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"samples were labeled for the GeneChip Human Transcriptome Array 2.0 (HTA 2.0, Affymetrix)",0.9,Accept,Experimental Usage
REScfeb8a14,BioNavigator software V.6.3,Analysis Software,V.6.3,,,,,,,BioNavigator software V.6.3,PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,software-based image analysis (BioNavigator software V.6.3 from PamGene),0.9,Accept,Experimental Usage
RESb021dd16,IBM SPSS Statistics,Analysis Software,27.01,,,,,,,IBM SPSS Statistics,PMID:39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,,Statistical analyses were conducted using IBM SPSS Statistics (version 27.01),0.8,Accept,Experimental Usage
RES411db040,PLINK,Analysis Software,,,,,,,,PLINK,PMID:41411243 | PMID:32869517,10.1371/journal.pgen.1011976 | 10.1002/mgg3.1400,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping. | Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"we implemented stringent quality control (QC) measures on the whole-exome sequencing (WES) data using PLINK [ 51 ] | multidimensional scaling (MDS) analysis estimating pairwise identity by descent (IBD) for all pairs of founders using independent SNPs in PLINK (Purcell et al., 2007)",0.9,Accept,Experimental Usage
RES64490b01,skyscan 1172,Analysis Software,,,,,,,,skyscan 1172,PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,Bone samples were analyzed with low (6 µm voxel) or high (up to 1 µm voxel) resolution microCT from skyscan 1172,0.9,Accept,Experimental Usage
RES916be9c3,Labview 7.0,Analysis Software,7.0,,,,,,,Labview 7.0,PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"Both the camera and the tensile tester were controlled by customized software (Labview 7.0, National Instruments)",0.85,Accept,Experimental Usage
RES485376e5,Seurat V3.0,Package/Library,V3.0,R,,,,,,Seurat V3.0,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Data were analyzed by the Seurat V3.0 package in the R programming environment,0.9,Accept,Experimental Usage
RESe79bb22a,STAR 2.4.2.8,Analysis Software,2.4.2.8,,,,,,,STAR 2.4.2.8,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The raw transcript counts were aligned to Refseq related to the build GRCh38-mm10 using STAR 2.4.2.8,0.9,Accept,Experimental Usage
RES608a1727,GSVA package,Package/Library,,R,,,,,,GSVA package,PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The ssgesa was calculated by the GSVA package with default settings,0.9,Accept,Experimental Usage
RES4382aa17,PredictSNP2,Web Application,,,https://loschmidt.chemi.muni.cz/predictsnp/,,,,,PredictSNP2,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,The effects of mutations on protein functions were analyzed using the PredictSNP2 tool (https://loschmidt.chemi.muni.cz/predictsnp/),0.9,Accept,Experimental Usage
RES0d35ceb2,iStable,Web Application,,,,,,,,iStable,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,"The iStable-integrated server, accessible at predictor.nchu.edu.tw/iStable, features two machine learning-based tools",0.9,Accept,Experimental Usage
RESb96d24ac,Align GVGD,Web Application,,,http://agvgd.hci.utah.edu/agvgd_input.php,,,,,Align GVGD,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,Align-GVGD (http://agvgd.hci.utah.edu/agvgd_input.php) is another tool that applies the Grantham difference,0.9,Accept,Experimental Usage
RESdad0f538,SNPeffect 4.0,Analysis Software,4.0,,,,,,,SNPeffect 4.0,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,These mutations were subjected to further phenotyping analysis using SNPeffect 4.0,0.85,Accept,Experimental Usage
RES7976172c,iMutant 2.0,Analysis Software,2.0,,,,,,,iMutant 2.0,PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,We selected the iMutant 2.0 and MUpro algorithms to predict the thermodynamic parameter changes,0.85,Accept,Experimental Usage
RES24674433,Gel-Pro Analyzer 4.0 software,Analysis Software,4.0,,,,,,,Gel-Pro Analyzer 4.0 software,PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,"Densitometry analysis was performed with Gel-Pro Analyzer 4.0 software (Media Cybernetics; Silver Spring, MD)",0.85,Accept,Experimental Usage
REScb0492c9,R statistical package,Analysis Software,,R,http://cran.r-project.org/,,,,,R statistical package,PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,All the analyses were implemented by the comprehensive statistical package R (http://cran.r-project.org/),0.8,Accept,Experimental Usage
RES8f454701,CHOPCHOP,Web Application,,,https://chopchop.cbu.uib.no/,,,,,CHOPCHOP,PMID:33934112 | PMID:39415595,10.1038/s41419-021-03716-6 | 10.1242/dmm.050862,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. | Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,CHOPCHOP (https://chopchop.cbu.uib.no/) was used to identify the sgRNA sequence | gRNAs for zebrafish nf2a and nf2b (Table S1) were designed using CHOP-CHOP,0.9,Accept,Experimental Usage
RES6036c7e5,Vevo 2100 micro-imaging system,Analysis Software,,,,,,,,Vevo 2100 micro-imaging system,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Sonographic measurement was performed using a Vevo 2100 micro-imaging system (VisualSonics, Amsterdam, Netherlands)",0.9,Accept,Experimental Usage
RES5c2e2784,Vevo software version 5.0.0,Analysis Software,5.0.0,,,,,,,Vevo software version 5.0.0,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,Three-dimensional images of the xenografts were generated and analyzed using the Vevo software version 5.0.0 to calculate their size in volume,0.9,Accept,Experimental Usage
RESa92dbc05,Chipster software,Analysis Software,,,http://chipster.csc.fi/,,,,,Chipster software,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,Alignment and analysis was performed using a Galaxy server and open source Chipster software (http://chipster.csc.fi/),0.85,Accept,Experimental Usage
RESaf746748,R bioconductor,Package/Library,,R,http://www.bioconductor.org/,,,,,R bioconductor,PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,as well as R bioconductor (http://www.bioconductor.org/) tools for calculating similarity clusters on a Galaxy server,0.8,Accept,Experimental Usage
RESfaa62e1c,Dragen program,Analysis Software,,,,,,,,Dragen program,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Reads were mapped to the genome and variants identified using the Dragen program with default settings,0.9,Accept,Experimental Usage
RES43dbc6be,GATK pipeline,Pipeline,,,,,,,,GATK pipeline,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,The resulting VCF files were then sorted and updated to remove errors and analysed using the GATK pipeline,0.9,Accept,Experimental Usage
RES90396f9b,HudsonAlpha RNA-seq data analysis pipeline,Pipeline,,,,,,,,HudsonAlpha RNA-seq data analysis pipeline,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Post-processing of the sequencing reads from RNA-seq experiments for each sample was performed using HudsonAlpha's unique in-house RNA-seq data analysis pipeline,0.9,Accept,Experimental Usage
RESb5c68f3e,TopHat v2.0,Analysis Software,v2.0,,,,,,,TopHat v2.0,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Raw reads were mapped to the reference human genome hg19 using TopHat v2.0 with the -p 4 and -r210 arguments,0.85,Accept,Experimental Usage
RES8e472223,Cufflinks v0.9.3,Analysis Software,v0.9.3,,,,,,,Cufflinks v0.9.3,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Reads were quantified by both Cufflinks v0.9.3,0.85,Accept,Experimental Usage
RES06c03c1a,Cutaneous NF Github repository,Web Application,,,http://www.github.com/Sage-Bionetworks/dermalNF,,,,,Cutaneous NF Github repository,PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"All data is currently stored in the synapse web portal, and is accessible using code in the Cutaneous NF Github repository at http://www.github.com/Sage-Bionetworks/dermalNF",0.95,Accept,Development
RESf17bfc6d,QuPath (v0.4.3),Analysis Software,v0.4.3,Java,,,,,,QuPath (v0.4.3),PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,QuPath (v0.4.3) was used to quantify the percentage of cells with positive or negative immunostaining,0.95,Accept,Experimental Usage
RES048c3696,R (version 4.3.1),Analysis Software,4.3.1,R,,,,,,R (version 4.3.1),PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,,"All statistical analyses were performed in R (version 4.3.1) using the 'survival', 'survminer', and 'stats' packages",0.85,Accept,Experimental Usage
RES2c30e9bb,R v3.6.3,Analysis Software,v3.6.3,R,,,,,,R v3.6.3,PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"A Shapiro-Wilk test (base R v3.6.3, shapiro.test function) was used to test the normality",0.9,Accept,Experimental Usage
RES03b7b6c3,BSDA v1.2.0,Package/Library,v1.2.0,R,,,,,,BSDA v1.2.0,PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"compared to estimate the P value of the real observations (real P value) (using BSDA v1.2.0, z.test function)",0.85,Accept,Experimental Usage
RES9139c053,gdata v2.18.0,Package/Library,v2.18.0,R,,,,,,gdata v2.18.0,PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,"resampled 10,000 times to produce 10,000 possible combinations of age-adjusted proportions (using gdata v2.18.0, resample function)",0.85,Accept,Experimental Usage
RESc5ec6718,ggplot2 v3.3.2,Package/Library,v3.3.2,R,,,,,,ggplot2 v3.3.2,PMID:36565307,10.1016/j.gim.2022.10.007,"COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.",,The distributions of bootstrapped P values were visualized using R (ggplot2 v3.3.2),0.85,Accept,Experimental Usage
RESe968d7f3,Affymetrix Mouse Gene 2.0 ST array,Analysis Software,,,,,,,,Affymetrix Mouse Gene 2.0 ST array,PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,All the probe sets on Affymetrix Mouse Gene 2.0 ST array (Mogene-2_0-st-v1.na33.2.mm10),0.9,Accept,Experimental Usage
RESd524a874,WebGestalt webserver,Web Application,,,http://bioinfo.vanderbilt.edu/webgestalt/,,,,,WebGestalt webserver,PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,Gene set enrichment analysis was performed using the WebGestalt webserver (http://bioinfo.vanderbilt.edu/webgestalt/),0.9,Accept,Experimental Usage
RESe16160e5,MedCalc,Analysis Software,v16.8.4,,,,,,,MedCalc,PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"Statistical analysis was performed using SPSS (v22, Chicago, IL, USA) and MedCalc (v16.8.4, Ostend, Belgium) software",0.85,Accept,Experimental Usage
RES9aaf818a,Stata 15,Analysis Software,15,,,,,,,Stata 15,PMID:37174087,10.3390/cancers15092621,Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study.,,"...All analyses were performed using Stata 15 (StataCorp, College Station, TX, USA)...",0.8,Accept,Experimental Usage
RES0a560581,10x Genomics Cell Ranger 7.0.1,Analysis Software,7.0.1,,,,,,,10x Genomics Cell Ranger 7.0.1,PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,BCL files were processed using 10x Genomics Cell Ranger 7.0.1,0.9,Accept,Experimental Usage
RES80d94a79,Seurat V3 package,Package/Library,V3,R,,,,,,Seurat V3 package,PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,Each data set was analyzed individually from its raw count matrix using the Seurat V3 package [29],0.9,Accept,Experimental Usage
RESc58f2a98,SAS software Version 9.4,Analysis Software,9.4,,,,,,,SAS software Version 9.4,PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,"The data were analyzed using SAS software Version 9.4 (SAS Institute, Cary, NC, USA), with the significance level set at 0.05",0.85,Accept,Experimental Usage
RES056c7ee9,Analyze 12.0,Analysis Software,12.0,,,,,,,Analyze 12.0,PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Using the multispectral neural network (MSNN) modeling tool available in Analyze 12.0 (AnalyzeDirect, Overland Park, KS)",0.9,Accept,Experimental Usage
RES74f910ae,MIM Encore 6.9.3,Analysis Software,6.9.3,,,,,,,MIM Encore 6.9.3,PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Measurements were made on a commercially available image analysis software (MIM Encore 6.9.3, MIM Software INC, Cleveland, OH)",0.9,Accept,Experimental Usage
RES434acf24,Genome Analysis Toolkit (GATK),Analysis Software,,,https://gatk.broadinstitute.org,,,,,Genome Analysis Toolkit (GATK),PMID:41564118 | PMID:39669605,10.1371/journal.pone.0340183 | 10.1016/j.gimo.2024.101816,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas. | Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,Variant calling of the germline samples was performed using The Genome Analysis Toolkit (https://gatk.broadinstitute.org) | SNVs/indel variants and SNPs were called using version 3.8 of the Genome Analysis Toolkit (GATK).,0.9,Accept,Experimental Usage
RES770b3603,nf-core sarek pipeline (v2.7.1),Pipeline,v2.7.1,,,,,,,nf-core sarek pipeline (v2.7.1),PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,WES and WGS data processing was performed with a modified version of the Nextflow nf-core 'sarek' data processing pipeline (v2.7.1),0.95,Accept,Experimental Usage
RES209cdc29,DeepVariant,Analysis Software,,,,,,,,DeepVariant,PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,The pipeline was modified to add DeepVariant as an additional variant-calling method,0.9,Accept,Experimental Usage
RES128ad42a,nf-core rnaseq pipeline (v3.5),Pipeline,v3.5,,,,,,,nf-core rnaseq pipeline (v3.5),PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Transcriptomic data processing was performed using the nf-core 'rnaseq' data processing pipeline (v3.5),0.95,Accept,Experimental Usage
RES5368995c,Ventana-785-Raman spectrometer,Analysis Software,,,,,,,,Ventana-785-Raman spectrometer,PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"guiding the signals from the Raman probe to the spectrometer (Ventana-785-Raman, Ocean Optics, Rochester, New York, USA)",0.9,Accept,Experimental Usage
RES919b5c77,SPSS software v. 21,Analysis Software,21,,,,,,,SPSS software v. 21,PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,Analyses of neuropsychological and clinical data were performed using SPSS software v. 21 (IBM),0.8,Accept,Experimental Usage
RES3e4d7975,DYNAMIC software,Analysis Software,V7.1.4,,,,,,,DYNAMIC software,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"DYNAMIC software (V7.1.4) was used to obtain the normalized time autocorrelation function, polydispersity, and the absolute molecular mass",0.85,Accept,Experimental Usage
RES99ad55bd,Spectra Manager,Analysis Software,V1.17.00,,,,,,,Spectra Manager,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,using the Spectra Manager control (V1. 17.00) and application (V1.3.00) software package (JASCO),0.8,Accept,Experimental Usage
RES3d781853,Bindworks,Analysis Software,version 3.1.5,,,,,,,Bindworks,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The data were analyzed using the manufacturer provided software Bindworks (version 3.1.5, Calorimetry Sciences Corp. Lindon, UT)",0.85,Accept,Experimental Usage
RES1ecb7d91,MantidPlot,Analysis Software,,,http://www.mantidproject.org/,,,,,MantidPlot,PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,Data reduction followed standard procedures that are implemented in MantidPlot (http://www.mantidproject.org/),0.85,Accept,Experimental Usage
RESa7cddf10,MATLAB (2019a),Analysis Software,2019a,MATLAB,,,,,,MATLAB (2019a),PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses,0.9,Accept,Experimental Usage
RES389a890b,SPM12 (version 7771),Analysis Software,7771,,,,,,,SPM12 (version 7771),PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses,0.9,Accept,Experimental Usage
RESe06b3686,EEGLAB (version 13.6.5b),Package/Library,13.6.5b,,,,,,,EEGLAB (version 13.6.5b),PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Custom functions calling several functions from EEGLAB (version 13.6.5b) and FieldTrip (embedded in SPM release) were used,0.9,Accept,Experimental Usage
RES1429b3d6,ATLAS.ti (Version 9),Analysis Software,Version 9,,,,,,,ATLAS.ti (Version 9),PMID:41602242,10.7759/cureus.100193,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,,"The coded transcripts were entered into ATLAS.ti (Version 9; Kansas City, MO)",0.95,Accept,Experimental Usage
RESaf6a483a,HaploReg v2,Web Application,v2,,,,,,,HaploReg v2,PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,mQTL putative genes were obtained from the HaploReg v2 web browser ( 36 ),0.85,Accept,Experimental Usage
RES573642f4,SPM12 v7771,Analysis Software,v7771,,,,,,,SPM12 v7771,PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"Images were segmented using SPM12 v7771 (Wellcome Trust Centre for Neuroimaging, University College London, United Kingdom)",0.85,Accept,Experimental Usage
RES7d32dfe2,MATLAB vR2020b,Analysis Software,vR2020b,MATLAB,,,,,,MATLAB vR2020b,PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"Images were segmented using SPM12 v7771 (Wellcome Trust Centre for Neuroimaging, University College London, United Kingdom) through MATLAB vR2020b",0.8,Accept,Experimental Usage
RES1d3b461e,MRIcroGL,Analysis Software,,,https://www.nitrc.org/projects/mricrogl,,,,,MRIcroGL,PMID:35673329,10.1093/texcom/tgac021,Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.,,"For visualization purposes, all thresholded SPM maps were imported into MRIcroGL (https://www.nitrc.org/projects/mricrogl)",0.85,Accept,Experimental Usage
RESd6f14488,Cell Ranger 5.0.1,Analysis Software,5.0.1,,,,,,,Cell Ranger 5.0.1,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,"Cell Ranger 5.0.1 (10x Genomics, https://www.10xgenomics.com/) was used to process the raw sequencing data.",0.9,Accept,Experimental Usage
RESb9435741,Seurat R package,Package/Library,v4.0.2,R,,,,,,Seurat R package,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,The gene expression matrix from Cell Ranger was used as input to the Seurat R package (v4.0.2) for downstream analysis (53).,0.9,Accept,Experimental Usage
RESce05312e,Proteome Discoverer 2.4,Analysis Software,2.4,,,,,,,Proteome Discoverer 2.4,PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,Data were acquired by the facility core and analyzed using Proteome Discoverer 2.4 (Thermo Fisher Scientific)...,0.9,Accept,Experimental Usage
RES1f3f5123,Salmon v1.8.0,Analysis Software,v1.8.0,,,,,,,Salmon v1.8.0,PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,,RNA-Seq data from real and in silico mixed samples was aligned with Salmon v1.8.0,0.9,Accept,Experimental Usage
RESd8a5185e,nCounter Sprint Profiler,Analysis Software,,,,,,,,nCounter Sprint Profiler,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Gene expression analysis was conducted on the nCounter Sprint Profiler (NanoString Technologies, Inc.)",0.9,Accept,Experimental Usage
RES9b7e9f10,nSolver Advanced Analysis Software version 4.0,Analysis Software,4.0,,,,,,,nSolver Advanced Analysis Software version 4.0,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Quality control, normalization, differential expression and pathway analysis were performed using nSolver Advanced Analysis Software (version 4.0)",0.9,Accept,Experimental Usage
RES09bb9684,Omics Playground v2.7.18,Analysis Software,v2.7.18,,,,,,,Omics Playground v2.7.18,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Raw count matrices with sample metadata deposited on GEO were reanalyzed using the Omics Playground v2.7.18 Platform,0.9,Accept,Experimental Usage
RES76905471,UCSC Xena browser,Web Application,,,,,,,,UCSC Xena browser,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Publicly available RNA sequencing data was also obtained from the TARGET TCGA GTEx database using the UCSC Xena browser (RRID:SCR_018938),0.9,Accept,Experimental Usage
RESd22cb21b,IDEP.92,Web Application,0.92,,,,,,,IDEP.92,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Principal Component Analysis (PCA) was conducted in IDEP.92 using log2 transformed, normalized counts as input",0.9,Accept,Experimental Usage
RESc3108fc8,ComplexHeatmap R/Bioconductor package,Package/Library,,R,,,,,,ComplexHeatmap R/Bioconductor package,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,were generated using the ComplexHeatmap R/Bioconductor package (RRID:SCR_017270),0.9,Accept,Experimental Usage
RESab1a2333,Scanpy,Package/Library,,Python,,,,,,Scanpy,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Data preprocessing and visualization was performed using Scanpy (RRID:SCR_018139) in Python,0.9,Accept,Experimental Usage
RESd6a8a408,infercnvpy package,Package/Library,,,https://github.com/icbi-lab/infercnvpy,,,,,infercnvpy package,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,the infercnvpy package (https://github.com/icbi-lab/infercnvpy) was used to detect copy number variations,0.85,Accept,Experimental Usage
RES000e3e56,HALO Image Analysis software version 2.0.5,Analysis Software,2.0.5,,,,,,,HALO Image Analysis software version 2.0.5,PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Quantitative immunohistochemical analysis for BIRC5 and CENPF was conducted using the Cytonuclear IHC module of HALO Image Analysis software (version 2.0.5),0.9,Accept,Experimental Usage
RES8a821885,conumee,Package/Library,,R,,,,,,conumee,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"To generate compound CNV plots using the DNA methylation data, we used the conumee package in Bioconductor",0.9,Accept,Experimental Usage
RES956c7a77,Haplotype Caller,Analysis Software,,,,,,,,Haplotype Caller,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Haplotype Caller, MuTect1 v1.1.7 and Strelka v1.0.13 were run to create raw variant call files (VCFs)",0.9,Accept,Experimental Usage
RES029e8101,MuTect1,Analysis Software,v1.1.7,,,,,,,MuTect1,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Haplotype Caller, MuTect1 v1.1.7 and Strelka v1.0.13 were run to create raw variant call files",0.95,Accept,Experimental Usage
RES51409ca6,Variant Effect Predictor,Analysis Software,v92,,,,,,,Variant Effect Predictor,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Raw VCF files were annotated with Variant Effect Predictor v92,0.95,Accept,Experimental Usage
RES84f238e5,Sequenza,Analysis Software,v 2.1.2,,,,,,,Sequenza,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"Additional analysis was applied to detect allele specific copy number profiles, loss of heterozygosity, and to estimate ploidy/cellularity using Sequenza for matched tumor/normal pairs",0.95,Accept,Experimental Usage
RESd20d8b92,MAVIS,Analysis Software,2.2.6,,,,,,,MAVIS,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,SVs were validated and visualized using MAVIS (version 2.2.6),0.95,Accept,Experimental Usage
RES66b6a420,FusionCatcher,Analysis Software,,,,,,,,FusionCatcher,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,We used FusionCatcher to detect novel gene fusions,0.9,Accept,Experimental Usage
RES456ad689,STAR aligner,Analysis Software,2.4.2a,,,,,,,STAR aligner,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,"The reads were aligned to the human reference genome, hg38 using the star aligner (version 2.4.2a)",0.95,Accept,Experimental Usage
RESff115358,AutoAnnotate,Plugin,1.2,,,,,,,AutoAnnotate,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,Highly related pathways were grouped into a theme and labeled by AutoAnnotate (version 1.2) in Cytoscape,0.9,Accept,Experimental Usage
RES5ac7ae7f,Enrichment Map,Plugin,3.1,,,,,,,Enrichment Map,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,GSEA results were visualized using the Enrichment Map app (Version 3.1) in Cytoscape,0.9,Accept,Experimental Usage
RES5a5d9d66,CIBERSORT,Package/Library,,R,,,,,,CIBERSORT,PMID:33025139 | PMID:32098059 | PMID:37410426,10.1007/s00401-020-02230-x | 10.3390/genes11020226 | 10.1158/1078-0432.CCR-23-0749,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. | Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1. | CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,"We used CIBERSORT Bioconductor package to perform deconvolution and estimate the abundances of cell types | we used two tumor deconvolution methods: CIBERSORT and MCP-counter, as implemented through the ""immunedeconv"" R package [29, 30, 31]. | DEGs were mapped to their human orthologs and were further analyzed using CIBERSORT (RRID: SCR_016955)",0.9,Accept,Experimental Usage
RESd28a29ff,GeneMapper software,Analysis Software,,,,,,,,GeneMapper software,PMID:33025139,10.1007/s00401-020-02230-x,"Epigenomic, genomic, and transcriptomic landscape of schwannomatosis.",,electrophoresis data were analyzed using GeneMapper software (Life Technologies),0.9,Accept,Experimental Usage
RES20c8c985,Agilent 1200 HPLC,Analysis Software,,,,,,,,Agilent 1200 HPLC,PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,Ketotifen was quantified in plasma and nerve tissue samples from ketotifen-treated Nf1;flox/flox PostnCre+ mice (n = 3) by HPLC-MS/MS (Agilent 1200 HPLC and ABI 3200 MS/MS),0.9,Accept,Experimental Usage
RES0c91d2d2,ABI 3200 MS/MS,Analysis Software,,,,,,,,ABI 3200 MS/MS,PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,Ketotifen was quantified in plasma and nerve tissue samples from ketotifen-treated Nf1;flox/flox PostnCre+ mice (n = 3) by HPLC-MS/MS (Agilent 1200 HPLC and ABI 3200 MS/MS),0.9,Accept,Experimental Usage
RES9b13834a,Synapse,Database,,,https://doi.org/10.7303/syn4939906,,,,,Synapse,PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,...Primary files [15] were accessed from Single Agent Screens through Synapse https://doi.org/10.7303/syn4939906...,0.8,Accept,Experimental Usage
RES5b11eb44,RENOVO-NF1,Analysis Software,,R,https://github.com/mazzalab-ieo/renovo,,,,,RENOVO-NF1,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"Here, we optimized our random forest-based predictor RENOVO for NF1 variant interpretation. RENOVO was developed using an approach of 'database archaeology'",0.95,Accept,Development
RES48240260,Mutation Taster,Web Application,,,,,,,,Mutation Taster,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,The effects on genes and proteins of the variants identified were predicted based on the Mutation Taster (http://www.mutationtaster.org),0.9,Accept,Experimental Usage
RES433ff09d,HGMD,Database,,,,,,,,HGMD,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"HGMD (Human Genome Mutation Database—Institute of Medical Genetics, Cardiff, Wales, UK; http://www.hgmd.cf.ac.uk/ac/index.php",0.9,Accept,Experimental Usage
RES5c98d57c,LOVD,Database,,,,,,,,LOVD,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,LOVD. (Leiden Open Variation Database; http://www.LOVD.nl.NF1),0.9,Accept,Experimental Usage
RES3e34cc3d,PolyPhen-2,Web Application,,,,,,,,PolyPhen-2,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,Novel variants with amino acid changes were further examined for their disease causing. potential using PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/bgi.shtml),0.9,Accept,Experimental Usage
RESc295a77c,ESE Finder,Web Application,,,,,,,,ESE Finder,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,and the ESE Finder (http://rulai.cshl.edu/cgibin/tools/ESE3/esefinder.cgi?process=home) tools,0.9,Accept,Experimental Usage
RESad917b33,GnomAD,Database,v.2.1.1,,,,,,,GnomAD,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,the GnomAD v.2.1.1 (https://gnomad.broadinstitute.org) and 1000 genomes databases were used,0.9,Accept,Experimental Usage
RESb25d3de9,1000 Genomes,Database,2015 aug,,,,,,,1000 Genomes,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"1000 genomes (https://www.internationalgenome.org, release 2015 aug) databases were used",0.9,Accept,Experimental Usage
RES6673fdb1,cutpointR,Package/Library,1.1.2,R,,,,,,cutpointR,PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"For threshold optimization, we used cutpointR version 1.1.2, maximizing the 'accuracy' metric",0.85,Accept,Experimental Usage
RES14f4c246,NF Research Tools Database,Database,,,https://tools.nf.synapse.org/,,,,,NF Research Tools Database,PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,"...the NF Research Tools Database, is an open-access database that enables the exploration and discovery of information about NF type 1-relevant animal models, cell lines, antibodies...",0.95,Accept,Development
RESca5bf041,JSON-LD schema,Other,2.0.0,,https://github.com/nf-osi/nf-research-tools-schema,,,,,JSON-LD schema,PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...We constructed a JSON-LD schema from the data model to make it machine-readable (version 2.0.0 at the time of writing...,0.85,Accept,Development
RESa57cf842,Synapse collaborative science platform,Web Application,,,,,,,,Synapse collaborative science platform,PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...but all database tables and a variety of 'joined' tables are available for anyone to access on the Synapse collaborative science platform...,0.9,Accept,Experimental Usage
RES1e211360,Salmon v1.4,Analysis Software,v1.4,Unknown,,,,,,Salmon v1.4,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Raw FASTQ files were analyzed using the Salmon v1.4 alignment tool,0.9,Accept,Experimental Usage
RES08b42fa6,BWA-MEM2 v2.1,Analysis Software,v2.1,Unknown,,,,,,BWA-MEM2 v2.1,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Reads were aligned to hg38 using BWA-MEM2 v2.1,0.9,Accept,Experimental Usage
RES4cd3658d,GATK v4.1.9.0,Analysis Software,v4.1.9.0,Unknown,,,,,,GATK v4.1.9.0,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Base quality score recalibration (BQSR) was performed with GATK v4.1.9.0 BaseRecalibrator,0.9,Accept,Experimental Usage
RESb6bf688d,MCP-Counter,Analysis Software,,Unknown,,,,,,MCP-Counter,PMID:38744290 | PMID:32098059,10.1016/j.crmeth.2024.100772 | 10.3390/genes11020226,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening. | Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"To assess the cell type of origin in the organoid models we used the tumor deconvolution algorithm MCP-Counter | we used two tumor deconvolution methods: CIBERSORT and MCP-counter, as implemented through the ""immunedeconv"" R package [29, 30, 31].",0.9,Accept,Experimental Usage
RESfe881c7f,BSBolt,Analysis Software,,Unknown,,,,,,BSBolt,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,raw fastq files obtained by RRBS were analyzed using BSBolt,0.9,Accept,Experimental Usage
RES251b421c,metilene v0.2-8,Analysis Software,v0.2-8,Unknown,,,,,,metilene v0.2-8,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Differentially methylated regions were detected using metilene v0.2-8,0.9,Accept,Experimental Usage
RESf3ee434f,DELLY v1.1.3,Analysis Software,v1.1.3,Unknown,,,,,,DELLY v1.1.3,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Structural variants and copy number variation were called using DELLY v1.1.3,0.9,Accept,Experimental Usage
RESd7883caa,InterVar,Analysis Software,update-2021-08-version,Unknown,,,,,,InterVar,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Germline variants are annotated using InterVar (update-2021-08-version),0.9,Accept,Experimental Usage
RES78e81864,rare disease workflows,Workflow,,Unknown,https://github.com/Sage-Bionetworks/rare-disease-workflows/tree/main/rna-seq-workflow,,,,,rare disease workflows,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,Our RNAseq analyses leverage the rare disease workflows at https://github.com/Sage-Bionetworks/rare-disease-workflows/tree/main/rna-seq-workflow,0.85,Accept,Experimental Usage
RES71defe01,cNFOrganoidAnalysis,Analysis Software,,Unknown,https://github.com/PNNL-CompBio/cNFOrganoidAnalysis,,,,,cNFOrganoidAnalysis,PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,,All computational tools used to generate Figures 4 and 5 for this manuscript are available on https://github.com/PNNL-CompBio/cNFOrganoidAnalysis,0.9,Accept,Development
RES6133f4a9,Clustree,Package/Library,,R,https://github.com/lazappi/clustree,,,,,Clustree,PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,cluster number optimization was performed by comparing multiple cluster resolutions using Clustree,0.85,Accept,Experimental Usage
RESea1d0ccd,Statistical Parametric Mapping toolbox (SPM8),Analysis Software,SPM8,,,,,,,Statistical Parametric Mapping toolbox (SPM8),PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,"PET images were spatially processed using the Statistical Parametric Mapping toolbox (SPM8, Wellcome Trust Centre for Neuroimaging, 2008)",0.95,Accept,Experimental Usage
RES93df18c0,Matlab 7.12.0,Analysis Software,7.12.0,MATLAB,,,,,,Matlab 7.12.0,PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,"implemented within Matlab 7.12.0 (MathWorks, Natick, MA, USA)",0.9,Accept,Experimental Usage
RESb7e0757e,kernlab R library,Package/Library,,R,,,,,,kernlab R library,PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,we used the Gaussian Process regression (GPR) implementation available within kernlab R library,0.9,Accept,Experimental Usage
RES1a2d5f86,PLIER,Package/Library,,R,,,,,,PLIER,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [33], ""PLIER"" [26], ""synapser"" [34], ""tximport"" [35], ""immundeconv"" [35], and ""viper"" [32].",0.9,Accept,Experimental Usage
RESebbc5a7d,vcf2maf,Command-line Tool,,,https://github.com/mskcc/vcf2maf,,,,,vcf2maf,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Variant call format (VCF) files were processed using ""vcf2maf"" (https://github.com/mskcc/vcf2maf)",0.85,Accept,Experimental Usage
RES548c937d,MultiPLIER,Analysis Software,,,https://github.com/greenelab/multi-plier,,,,,MultiPLIER,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"We analyzed transcriptomic data from NF in the context of latent variables from MultiPLIER, a machine learning resource designed to aid in rare disease analyses [27].",0.9,Accept,Experimental Usage
RES85940ac4,metaVIPER,Analysis Software,,,,,,,,metaVIPER,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,We applied the metaVIPER algorithm [32] to infer protein regulatory activity based on the tissue gene expression profiles.,0.9,Accept,Experimental Usage
RES4eb59858,NF Data Portal,Database,,,,,,,,NF Data Portal,PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,All data analyzed in this article are stored on the NF Data Portal [24] (http://nfdataportal.org),0.9,Accept,Experimental Usage
RESabcab82f,R 4.0.3,Analysis Software,4.0.3,R,,,,,,R 4.0.3,PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,Data standardization was performed using the R 4.0.3,0.9,Accept,Experimental Usage
RES954bfcbc,miRTarBase,Database,,,,,,,,miRTarBase,PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"we retrieved miRNA information from the miRTarBase database, including, over 50,000 experimentally validated miRNA-target associations",0.9,Accept,Experimental Usage
RESc66542d3,connectivity map (CMap),Database,,,,,,,,connectivity map (CMap),PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,we uploaded our list of up- and down-regulated genes into the connectivity map (CMap) database,0.9,Accept,Experimental Usage
RESee38797a,SPSS V.23,Analysis Software,V.23,,,,,,,SPSS V.23,PMID:28848060,10.1136/jmedgenet-2017-104519,Genetic Severity Score predicts clinical phenotype in NF2.,,Statistical analyses were undertaken using SPSS V.23,0.8,Accept,Experimental Usage
RES5083d89d,CLC-workbench,Analysis Software,,,,,,,,CLC-workbench,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"Variants were validated by Sanger sequencing and analyzed using CLC-workbench (Qiagen, Hilden, Germany)",0.9,Accept,Experimental Usage
RES5cfa6887,PredictProtein,Web Application,,,https://www.PredictProtein.org,,,,,PredictProtein,PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Analyses of in silico protein modifications by the exon skipping were performed using the web-server version of PredictProtein,0.95,Accept,Experimental Usage
RES8baf5a58,"MATLAB (R2008a, MathWorks, Natick, MA, USA)",Analysis Software,R2008a,MATLAB,,,,,,"MATLAB (R2008a, MathWorks, Natick, MA, USA)",PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"Stimuli were generated with MATLAB (R2008a, MathWorks, Natick, MA, USA) and presented with the stimulation software STIM 2",0.85,Accept,Experimental Usage
RES77231e6e,"STIM 2 (Neuroscan, Charlotte, NC, USA)",Analysis Software,2,,,,,,,"STIM 2 (Neuroscan, Charlotte, NC, USA)",PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"presented with the stimulation software STIM 2 (Neuroscan, Charlotte, NC, USA) with a display resolution of 1,280 × 1,024 × 32",0.9,Accept,Experimental Usage
RESd4f97244,Scan 4.5 (Neuroscan),Analysis Software,4.5,,,,,,,Scan 4.5 (Neuroscan),PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,Data analysis was performed with Scan 4.5 (Neuroscan). We started the analysis by correcting the eye blinking artifacts,0.9,Accept,Experimental Usage
RES310923ba,"IBM SPSS Statistics, version 19",Analysis Software,19,,,,,,,"IBM SPSS Statistics, version 19",PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"All statistical analyses were performed with IBM SPSS Statistics, version 19, software (IBM Corporation, Armonk, NY, USA)",0.85,Accept,Experimental Usage
RES77afb919,WGCNA package v1.69,Package/Library,v1.69,R,,,,,,WGCNA package v1.69,PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,The conserved gene regulation networks and the correlation between drug responses and the gene network were determined using the WGCNA package v1.69,0.85,Accept,Experimental Usage
RESf146d680,Leiden Open Variation Database (LOVD),Database,,,www.lovd.nl,,,,,Leiden Open Variation Database (LOVD),PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,The publically accessible variant databases included were Leiden Open Variation Database (LOVD) ( www.lovd.nl ),0.85,Accept,Experimental Usage
RESc884ba8e,ClinVar NCBI,Database,,,www.ncbi.nlm.nih.gov/clinvar,,,,,ClinVar NCBI,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,ClinVar NCBI ( www.ncbi.nlm.nih.gov/clinvar ),0.85,Accept,Experimental Usage
RES3fcbeb26,Human Gene Mutation Database (HGMD),Database,,,www.hgmd.cf.ac.uk/ac/all.php,,,,,Human Gene Mutation Database (HGMD),PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,the Human Gene Mutation Database (HGMD) ( www.hgmd.cf.ac.uk/ac/all.php ),0.85,Accept,Experimental Usage
RES0419c353,Clinical Interpretation of Variants in Cancer (CIViC),Database,,,https://civicdb.org/home,,,,,Clinical Interpretation of Variants in Cancer (CIViC),PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Clinical Interpretation of Variants in Cancer (CIViC) ( https://civicdb.org/home ),0.85,Accept,Experimental Usage
RES5e648a57,Mastermind Genomic Search Engine,Web Application,,,https://www.genomenon.com/mastermind,,,,,Mastermind Genomic Search Engine,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Mastermind Genomic Search Engine ( https://www.genomenon.com/mastermind ),0.85,Accept,Experimental Usage
RESdfaa8d1e,Alamut Visual version 2.15,Analysis Software,2.15,,,,,,,Alamut Visual version 2.15,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Variants were imported into the clinical prediction software Alamut Visual version 2.15 (SOPHiA GENETICS),0.9,Accept,Experimental Usage
RES98431581,gnomAD v2.1.1,Database,v2.1.1,,gnomad.broadinstitute.org,,,,,gnomAD v2.1.1,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Variant frequencies and ExAC constraint metrics were obtained from gnomAD v2.1.1 ( gnomad.broadinstitute.org ),0.9,Accept,Experimental Usage
RES050c956d,UCSC LiftOver tool,Web Application,,,genome.ucsc.edu/cgi-bin/hgLiftOver,,,,,UCSC LiftOver tool,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,UCSC LiftOver tool was used for any genomic co‐ordinate conversions between genome builds GRCh37/hg19 and GRCh38/hg38,0.85,Accept,Experimental Usage
RES712603ac,alleleFrequencyApp,Web Application,,,cardiodb.org/allelefrequencyapp,,,,,alleleFrequencyApp,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Maximum credible population allele frequency was determined using the alleleFrequencyApp ( cardiodb.org/allelefrequencyapp ),0.85,Accept,Experimental Usage
RESa58e05eb,CanVar-UK cancer predisposition gene variant database,Database,,,www.canvaruk.org,,,,,CanVar-UK cancer predisposition gene variant database,PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,CanVar‐UK cancer predisposition gene variant database ( www.canvaruk.org ) was used in the search for further variant information,0.85,Accept,Experimental Usage
RES055400d2,Beta Imager 2000Z Digital Beta Imaging System,Analysis Software,,,,,,,,Beta Imager 2000Z Digital Beta Imaging System,PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"Quantitation was performed using the Beta Imager 2000Z Digital Beta Imaging System (Biospace, France)",0.9,Accept,Experimental Usage
REScbc272d6,Siemens Focus F220,Analysis Software,,,,,,,,Siemens Focus F220,PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,data acquired as 1h dynamic scans using the Siemens Focus F220 and Inveon scanners,0.9,Accept,Experimental Usage
RES917e20eb,Illumina bcl2fastq v1.8.4 software,Analysis Software,v1.8.4,,,,,,,Illumina bcl2fastq v1.8.4 software,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,FASTQ files were generated from Binary Cluster Files (.bcl) using the Illumina bcl2fastq v1.8.4 software with parameters set as per vendor's specifications,0.9,Accept,Experimental Usage
RES16c2d009,Burrows-Wheeler Aligner v0.7.10,Analysis Software,v0.7.10,,,,,,,Burrows-Wheeler Aligner v0.7.10,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,FASTQ files were aligned to the human genome reference hg19 (GRCh37) using the Burrows-Wheeler Aligner v0.7.10 algorithm with default settings,0.9,Accept,Experimental Usage
RES08a312fd,Picard Tools v1.119,Analysis Software,v1.119,,,,,,,Picard Tools v1.119,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,BAM files (.bam) were generated using Picard Tools v1.119,0.9,Accept,Experimental Usage
RESd27012fd,MDLVC v5.0,Analysis Software,v5.0,,,,,,,MDLVC v5.0,PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,variant calling was performed using in-house variant caller algorithm (MDLVC v5.0),0.9,Accept,Experimental Usage
RESba2244b1,HaplotypeCaller (Genome Analysis Tool Kit 3.3),Analysis Software,3.3,,,,,,,HaplotypeCaller (Genome Analysis Tool Kit 3.3),PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,cross referenced with HaplotypeCaller (Genome Analysis Tool Kit 3.3) under discovery mode,0.9,Accept,Experimental Usage
RES6f66388a,Integrated Genomics Viewer v2.3.4 (IGV),Analysis Software,v2.3.4,,,,,,,Integrated Genomics Viewer v2.3.4 (IGV),PMID:31462295,10.1186/s40478-019-0792-5,Telomere alterations in neurofibromatosis type 1-associated solid tumors.,,"All variant calls were inspected using Integrated Genomics Viewer v2.3.4 (IGV; Broad Institute, MIT Harvard, Cambridge, MA)",0.9,Accept,Experimental Usage
RESdfc0a5ac,CRISPResso2,Analysis Software,,,,,,,,CRISPResso2,PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"At least 10,000 high-quality reads were analyzed for each sample using CRISPResso2 (Clement et al., 2019)",0.9,Accept,Experimental Usage
RES14403ff2,Cellpose,Analysis Software,,Python,,,,,,Cellpose,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"images were further analyzed using Cellpose (Stringer et al., 2021) and ImageJ",0.9,Accept,Experimental Usage
RES1e4e1a36,Xenosplit,Analysis Software,,,,,,,,Xenosplit,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"For PDX sequence data, Xenosplit was used to filter mouse-derived reads",0.9,Accept,Experimental Usage
RES58bbcd74,Variant Effect Predictor (VEP),Analysis Software,,,,,,,,Variant Effect Predictor (VEP),PMID:37246765 | PMID:33591953,10.1093/neuonc/noad097 | 10.1172/jci.insight.146351,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Variant filtering and annotation were done using Variant Effect Predictor (VEP) | includes best-practices variant filtering and annotation with Variant Effect Predictor (VEP; version 95),0.9,Accept,Experimental Usage
RES10a6e3b2,maftools v2.10.0,Package/Library,v2.10.0,R,,,,,,maftools v2.10.0,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Somatic variant plots were created with maftools v2.10.0,0.9,Accept,Experimental Usage
RESdc6a3cd9,CNVkit V2.0,Analysis Software,V2.0,,,,,,,CNVkit V2.0,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,CNVkit V2.0 was used to infer and visualize copy number,0.9,Accept,Experimental Usage
RESf62302f2,DESeq2 package,Package/Library,,R,,,,,,DESeq2 package,PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Gene counts and transcript counts were normalized by using the DESeq2 package,0.9,Accept,Experimental Usage
RES9fbef3cb,R statistical software version 3.5.1,Analysis Software,3.5.1,R,,,,,,R statistical software version 3.5.1,PMID:32642740,10.1093/noajnl/vdaa003,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,,All analyses were done with R statistical software version 3.5.1,0.85,Accept,Experimental Usage
RESc4bec111,Seurat 3.1.0,Package/Library,3.1.0,R,,,,,,Seurat 3.1.0,PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Raw sequencing reads were processed using CellRanger (10 × Genomics) and Seurat 3.1.0,0.95,Accept,Experimental Usage
RESa0c2360d,CellChatDB,Database,1.5.0,R,,,,,,CellChatDB,PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,CellChatDB (version 1.5.0) was used to infer ligand–receptor interactions between and within individual subpopulations,0.9,Accept,Experimental Usage
RESb332914c,Space Ranger,Analysis Software,v1.2.1,,,,,,,Space Ranger,PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"Sequencing data were processed with Space Ranger (10 × genomics, v1.2.1)",0.9,Accept,Experimental Usage
RES7ca42a6d,Seurat v4.0.1,Package/Library,v4.0.1,R,,,,,,Seurat v4.0.1,PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,followed by analysis in R using the Seurat (v4.0.1) tool suite,0.95,Accept,Experimental Usage
RESa0ee0dca,R Studio PKNCA package (version 0.9.3),Package/Library,0.9.3,R,,,,,,R Studio PKNCA package (version 0.9.3),PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,Selumetinib plasma concentration–time data were analyzed using noncompartmental methods implemented in R (version 3.6) R Studio PKNCA package (version 0.9.3),0.9,Accept,Experimental Usage
RES6bc88167,STAR mapper (Version 2.4.1d),Analysis Software,2.4.1d,,,,,,,STAR mapper (Version 2.4.1d),PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,RNAseq reads were mapped with the STAR mapper (Version 2.4.1d),0.9,Accept,Experimental Usage
RESa161cad1,Picard tools,Analysis Software,,,https://github.com/broadinstitute/picard,,,,,Picard tools,PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Duplicate read pair detection was carried out with Picard tools,0.85,Accept,Experimental Usage
RES175cc88d,QURNAs,Pipeline,,,https://dataverse.nl/dataset.xhtml?persistentId=hdl:10411/LY8ZQ4,,,,,QURNAs,PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,an in-house developed tool (QURNAs) was used to calculate the enrichment score (ERS) for each splicing event,0.95,Accept,Development
RES44a0acf2,Alamut v2.15 (Interactive Biosoftware),Analysis Software,v2.15,,,,,,,Alamut v2.15 (Interactive Biosoftware),PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Alamut v2.15 (Interactive Biosoftware) was used to identify true splice-donor and acceptor sites,0.9,Accept,Experimental Usage
RES59dd9623,SNP & Variation Suite v8.3.4,Analysis Software,v8.3.4,,,,,,,SNP & Variation Suite v8.3.4,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Quality control for targeted gene sequencing data was done using SNP & Variation Suite v8.3.4 (http://goldenhelix.com/products/SNP_Variation/index.html),0.95,Accept,Experimental Usage
RES32f072b8,EMMAX,Analysis Software,,,,,,,,EMMAX,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"tests of association between each SNP and log‐transformed CALM number, adjusted for age, sex, and body surface area, were performed with EMMAX (Kang et al., 2010)",0.9,Accept,Experimental Usage
RES0dd19d9b,METAL,Analysis Software,,,,,,,,METAL,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Meta‐analyses between the CALM1 and CALM2 cohort studies were performed with METAL (Willer, Li, & Abecasis, 2010)",0.9,Accept,Experimental Usage
RES81b8831c,ComPaSS-GWAS,Analysis Software,,,,,,,,ComPaSS-GWAS,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"The second approach for corroboration of SNP associations used ComPaSS‐GWAS (Sabourin et al., 2018), a method based on complementary pairs stability selection",0.9,Accept,Experimental Usage
RES7995612b,Haploview 4.2,Analysis Software,4.2,,,,,,,Haploview 4.2,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Haploview 4.2 (Barrett, Fry, Maller, & Daly, 2005) was used to generate LD plots across the genome based on D' and r2 values",0.95,Accept,Experimental Usage
RESe08636d3,GTEx,Database,V7,,,,,,,GTEx,PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"eQTL results for all CALM‐associated SNPs and collated genes based on 749 normal skin tissues were then extracted from GTEx (V7, dbGaP Accession phs000424.v7.p2)",0.85,Accept,Experimental Usage
RES4eddd114,Adobe Photoshop CS2,Analysis Software,CS2,,,,,,,Adobe Photoshop CS2,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,An attached Olympus DP72 camera and Adobe Photoshop CS2 were used to capture the images,0.85,Accept,Experimental Usage
RES4e2257a9,Peak Scanner software from Applied Biosystems,Analysis Software,,,,,,,,Peak Scanner software from Applied Biosystems,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,The UCSF Genome Core using Peak Scanner software from Applied Biosystems performed PCR fragment analyses,0.9,Accept,Experimental Usage
RES9525be25,SDS3.0,Analysis Software,3.0,,,,,,,SDS3.0,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"Allelic discrimination plots generated by SDS3.0, an Applied Biosystems program used to make genotyping calls",0.85,Accept,Experimental Usage
RES3d91f830,COSMIC Database,Database,,,www.sanger.ac.uk/genetics/CGP/cosmic,,,,,COSMIC Database,PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"The Catalogue of Somatic Mutations in Cancer Database (COSMIC, www.sanger.ac.uk/genetics/CGP/cosmic, Wellcome Trust Sanger Institute, United Kingdom) was used to search for references",0.9,Accept,Experimental Usage
RES09e38364,Prizm v.4 (GraphPad),Analysis Software,v.4,,,,,,,Prizm v.4 (GraphPad),PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,All analyses were performed using Prizm v.4 (GraphPad),0.85,Accept,Experimental Usage
RES3edac9c5,nf-core/rnaseq (v3.11.2),Pipeline,v3.11.2,Unknown,,,,,,nf-core/rnaseq (v3.11.2),PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,Raw fastq files were processed using nf-core/rnaseq (v3.11.2),0.9,Accept,Experimental Usage
RESb243d697,salmon (v1.10.1),Analysis Software,v1.10.1,Unknown,,,,,,salmon (v1.10.1),PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,quantified using salmon: v1.10.1,0.9,Accept,Experimental Usage
RES56b0cb19,sva R package (v3.42.0),Package/Library,v3.42.0,R,,,,,,sva R package (v3.42.0),PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,ComBat from sva R package (v3.42.0) was used for batch correction,0.9,Accept,Experimental Usage
RES9e89b526,immunedeconv (v2.1.0),Package/Library,v2.1.0,R,,,,,,immunedeconv (v2.1.0),PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The batch corrected data was then analyzed using the immunedeconv (v2.1.0) package,0.9,Accept,Experimental Usage
RES66ea2b81,ggplot2 (v3.4.4),Package/Library,v3.4.4,R,,,,,,ggplot2 (v3.4.4),PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The analysis results were visualized using ggplot2 (v3.4.4) and ggridges (v0.5.5) libraries,0.9,Accept,Experimental Usage
RES3514bd4a,ggridges (v0.5.5),Package/Library,v0.5.5,R,,,,,,ggridges (v0.5.5),PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,The analysis results were visualized using ggplot2 (v3.4.4) and ggridges (v0.5.5) libraries,0.9,Accept,Experimental Usage
RES53e880b2,HALO imaging analysis software,Analysis Software,,Unknown,,,,,,HALO imaging analysis software,PMID:39321200,10.1158/1078-0432.CCR-24-1454,Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment.,,"analyzed with the HALO imaging analysis software (Indica Labs, Corrales, NM)",0.9,Accept,Experimental Usage
RES0d56b203,CLC Genomics Workbench 22,Analysis Software,22,,,,,,,CLC Genomics Workbench 22,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"Resulting FASTQ files were analyzed with CLC Genomics Workbench 22 (QIAGEN, Hilden, Germany)",0.9,Accept,Experimental Usage
REScc1096ae,CosinorPy Python package,Package/Library,,Python,,,,,,CosinorPy Python package,PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,numerical and graphical analysis was done using the CosinorPy Python package,0.9,Accept,Experimental Usage
RESdbef8074,pCLAMP 9.2,Analysis Software,9.2,,,,,,,pCLAMP 9.2,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,A MultiClamp 700B patch-clamp amplifier and pCLAMP 9.2 software (MDS Analytical Technologies) were used to acquire data,0.9,Accept,Experimental Usage
RES2e17e2c3,Volocity 4.2,Analysis Software,4.2,,,,,,,Volocity 4.2,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,The number of swellings per calyx was counted on 3D-rendered (Volocity 4.2; Improvision) images of calyces,0.9,Accept,Experimental Usage
RES9081ccf3,Igor 6.22A,Analysis Software,6.22A,,,,,,,Igor 6.22A,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,Electrophysiological data was analyzed with a custom written program in Igor 6.22A (WaveMetrics),0.85,Accept,Experimental Usage
RES4c4a6aba,NeuroMatic,Package/Library,2.00,,,,,,,NeuroMatic,PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Electrophysiological data was analyzed with a custom written program in Igor 6.22A (WaveMetrics) NeuroMatic (version 2.00, kindly provided by Dr. J. Rothman)",0.85,Accept,Experimental Usage
RES70a9e938,Disambiguate v1.0,Analysis Software,v1.0,,,,,,,Disambiguate v1.0,PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,"For PDX sequence data, Disambiguate v1.0 was used to filter out mouse-derived reads",0.9,Accept,Experimental Usage
RES6a8153a2,UPhyloplot2,Analysis Software,,,https://github.com/harbourlab/UPhyloplot2,,,,,UPhyloplot2,PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,The Uphyloplot2 (https://github.com/harbourlab/UPhyloplot2) was used to visualize the clonality,0.9,Accept,Experimental Usage
RES936b918a,HISAT2 version 2.2.1,Analysis Software,2.2.1,,,,,,,HISAT2 version 2.2.1,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"To align the reads, we employed HISAT2 version 2.2.1 against the GRCh38 human genome",0.9,Accept,Experimental Usage
RES4801bfe3,StringTie version 2.2.1,Analysis Software,2.2.1,,,,,,,StringTie version 2.2.1,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,Read counts were normalized by StringTie version 2.2.1,0.9,Accept,Experimental Usage
RES78022431,DEGseq version 1.48.0,Package/Library,1.48.0,R,,,,,,DEGseq version 1.48.0,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,Differential expression analysis was analyzed by DEGseq version 1.48.0,0.9,Accept,Experimental Usage
REScc9971fb,ClusterProfiler version 4.2.2,Package/Library,4.2.2,R,,,,,,ClusterProfiler version 4.2.2,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,the GSEA KEGG method with ClusterProfiler version 4.2.2 was applied,0.9,Accept,Experimental Usage
RESde4401b2,FlowJo™ software v10.8,Analysis Software,10.8,,,,,,,FlowJo™ software v10.8,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,The data were analyzed by v10.8 of FlowJo™ software,0.9,Accept,Experimental Usage
RES5b866505,Seahorse Wave Pro software,Analysis Software,,,,,,,,Seahorse Wave Pro software,PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"The analysis was performed with Seahorse Wave Pro software (Agilent Technologies, Santa Clara, CA, USA)",0.9,Accept,Experimental Usage
RESfc728315,Agilent Tapestation 4200,Analysis Software,,,,,,,,Agilent Tapestation 4200,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,Fragmented gDNAs were tested for size distribution and concentration using an Agilent Tapestation 4200 and Qubit dsDNA High Sensitivity kit.,0.9,Accept,Experimental Usage
RES922649b8,Varsome Clinical Software v.12.3.2,Analysis Software,v.12.3.2,,,,,,,Varsome Clinical Software v.12.3.2,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Candidate somatic variants, consisting of point mutations, insertions, and deletions were sorted out with Varsome Clinical Software v.12.3.2 (Saphetor, Lausanne, Switzerland).",0.95,Accept,Experimental Usage
RES3935f7c4,Plotly v4.9.3,Package/Library,v4.9.3,R,https://plotly-r.com,,,,,Plotly v4.9.3,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,The VAF plot was generated using Plotly v4.9.3 in the R environment (available from https://plotly-r.com).,0.85,Accept,Experimental Usage
RESa25dd705,CNVKit version 0.9.11,Analysis Software,0.9.11,,,,,,,CNVKit version 0.9.11,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Finally, to determine the profiles of the alterations in the number of copies, the CNV calling was also performed using the CNVKit version 0.9.11.",0.9,Accept,Experimental Usage
RESc90a85ba,ggplot2 v3.5.1,Package/Library,v3.5.1,R,https://ggplot2.tidyverse.org,,,,,ggplot2 v3.5.1,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,The output was then visualized using ggplot2 v3.5.1 (https://ggplot2.tidyverse.org).,0.85,Accept,Experimental Usage
RES56fa7930,GEPIA,Web Application,,,http://gepia.cancer-pku.cn/,,,,,GEPIA,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Kaplan–Meier survival curves were generated using GEPIA (http://gepia.cancer-pku.cn/) on the TCGA-SARC, TCGA-LUAD and TCGA-LUSC RNA-seq expression dataset.",0.9,Accept,Experimental Usage
RES892a05f1,Cluster Profiler v.4.0,Package/Library,v.4.0,R,,,,,,Cluster Profiler v.4.0,PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Gene Ontology (GO) and pathway enrichment analysis was performed using Cluster Profiler v.4.0, selecting statistically significant terms and pathways.",0.9,Accept,Experimental Usage
RES29d1c36d,MATLAB® version R2007a,Analysis Software,R2007a,MATLAB,,,,,,MATLAB® version R2007a,PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"statistical hypothesis testing were performed by the software package MATLAB®, version R2007a (The MathWorks, Inc., Natick, MA, USA)",0.8,Accept,Experimental Usage
RESfe1a1c35,FlowJo v10,Analysis Software,v10,,,,,,,FlowJo v10,PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,"data analyzed using FlowJo v10 (Becton Dickinson, RRID: SCR_008520)",0.9,Accept,Experimental Usage
RES8c32f138,HALO (Indica Labs),Analysis Software,,,,,,,,HALO (Indica Labs),PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"HALO (Indica Labs) or Aperio (Leica Biosystems, Wetzlar, Germany) Image Analysis software was used",0.9,Accept,Experimental Usage
REScc81e124,Aperio Image Analysis (Leica Biosystems),Analysis Software,,,,,,,,Aperio Image Analysis (Leica Biosystems),PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"HALO (Indica Labs) or Aperio (Leica Biosystems, Wetzlar, Germany) Image Analysis software was used",0.9,Accept,Experimental Usage
